syndrome	score	normalized_score
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	100.0
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.50613497	50.613496999999995
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.50196464	50.196464
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.5	50.0
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.5	50.0
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	33.3333
PLACENTAL INSUFFICIENCY	0.333333	33.3333
ACITRETIN/ETRETINATE EMBRYOPATHY	0.333333	33.3333
8P INVERTED DUPLICATION/DELETION SYNDROME	0.25485852000000003	25.485852000000005
CLEFT LIP/PALATE	0.25190476	25.190476
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.25098912	25.098912000000002
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.25	25.0
DYSTONIA 6, TORSION	0.25	25.0
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	25.0
HYPERPARATHYROIDISM 2	0.25	25.0
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	16.666700000000002
PFAPA SYNDROME	0.166667	16.666700000000002
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	16.666700000000002
PEMPHIGUS VULGARIS	0.166667	16.666700000000002
GRANULOMATOSIS WITH POLYANGIITIS	0.166667	16.666700000000002
PITYRIASIS RUBRA PILARIS	0.166667	16.666700000000002
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.14221727	14.221727000000001
DDOST-CDG	0.09160508000000002	9.160508000000002
BECKWITH-WIEDEMANN SYNDROME	0.08709349000000001	8.709349000000001
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08457552000000002	8.457552000000002
TRICHOHEPATOENTERIC SYNDROME 1	0.08336691	8.336691
MACS SYNDROME	0.08323265	8.323265000000001
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.08275089000000001	8.275089000000001
RIN2 SYNDROME	0.08237779	8.237779
TUBEROUS SCLEROSIS COMPLEX	0.08166244	8.166244
VAN MALDERGEM SYNDROME 1; VMLDS1	0.08144181	8.144181
VAN MALDERGEM SYNDROME 2; VMLDS2	0.08144181	8.144181
ETHYLMALONIC ENCEPHALOPATHY	0.08123344	8.123344000000001
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08057274	8.057274
CEREBROFACIOARTICULAR SYNDROME	0.07987686000000001	7.987686000000001
MARSHALL-SMITH SYNDROME; MRSHSS	0.07844055000000001	7.844055000000001
OROFACIODIGITAL SYNDROME TYPE 3	0.07791222	7.791222
TRISOMY 8P	0.07791222	7.791222
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	7.692310000000001
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	7.692310000000001
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	7.692310000000001
ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE	0.07692310000000001	7.692310000000001
FAMILIAL MEDIAN CLEFT OF THE UPPER AND LOWER LIPS	0.07692310000000001	7.692310000000001
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.07692310000000001	7.692310000000001
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.07692310000000001	7.692310000000001
FAMILIAL ANETODERMA	0.07692310000000001	7.692310000000001
KLEEFSTRA SYNDROME	0.07165067000000001	7.165067000000001
SMITH-FINEMAN-MYERS SYNDROME	0.06882231000000001	6.882231000000001
CHAR SYNDROME	0.06837657	6.837657
FRONTOMETAPHYSEAL DYSPLASIA	0.06725881	6.725881
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.0651125	6.51125
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.06406495	6.406495
OSTEOPETROSIS AND RELATED DISORDERS	0.06401745	6.401745
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.06348912	6.3489119999999994
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.06348912	6.3489119999999994
COFFIN-SIRIS SYNDROME 10; CSS10	0.0625	6.25
PYCNODYSOSTOSIS	0.0625	6.25
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE	0.0625	6.25
DENTAL NONERUPTION	0.0625	6.25
ABLEPHARON-MACROSTOMIA SYNDROME	0.04749035	4.749035
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.044396500000000005	4.43965
JUVENILE MYOCLONIC EPILEPSY	0.043200840000000004	4.3200840000000005
LIMB-MAMMARY SYNDROME	0.040942469999999995	4.094246999999999
SHPRINTZEN OMPHALOCELE SYNDROME	0.04042614	4.042614
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.040266550000000005	4.026655000000001
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.03989409000000001	3.9894090000000006
ACROCEPHALOPOLYDACTYLY	0.039450620000000006	3.9450620000000005
MEHMO SYNDROME; MEHMO	0.03857048	3.857048
LIP, HAMARTOMATOUS	0.0384615	3.84615
LIP, MEDIAN NODULE OF UPPER	0.0384615	3.84615
BAZEX SYNDROME; BZX	0.0384615	3.84615
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	3.84615
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	3.84615
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	3.84615
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	3.84615
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	3.84615
CYCLIC NEUTROPENIA	0.0384615	3.84615
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	3.84615
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	3.84615
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	3.84615
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	3.84615
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	3.84615
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	3.84615
JUVENILE ABSENCE EPILEPSY	0.0384615	3.84615
MAL DE MELEDA	0.0384615	3.84615
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.038061349999999994	3.8061349999999994
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.03639759000000001	3.6397590000000006
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.036238000000000006	3.6238000000000006
MYHRE SYNDROME	0.0359979	3.59979
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.03579577999999999	3.5795779999999993
OROFACIODIGITAL SYNDROME XIV; OFD14	0.03542288	3.5422879999999997
PALLISTER-HALL SYNDROME	0.03466212	3.4662119999999996
JOUBERT SYNDROME 26	0.03448045	3.4480450000000005
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.034432950000000004	3.4432950000000004
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.03391277	3.391277
ZECHI-CEIDE SYNDROME	0.033891019999999994	3.3891019999999994
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.033831139999999996	3.3831139999999995
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.033831139999999996	3.3831139999999995
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.033831139999999996	3.3831139999999995
ESOPHAGEAL ATRESIA	0.033443829999999994	3.344382999999999
HEART AND BRAIN MALFORMATION SYNDROME	0.033256759999999996	3.3256759999999996
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.03309717	3.309717
OCULOAURICULOFRONTONASAL SYNDROME	0.0329155	3.29155
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0329155	3.29155
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0329155	3.29155
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.0329155	3.29155
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.03226764	3.226764
CHROMOSOME 15Q14 DELETION SYNDROME	0.03192638	3.1926379999999996
HOLOPROSENCEPHALY 11	0.03192638	3.1926379999999996
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.03192638	3.1926379999999996
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.03192638	3.1926379999999996
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.03192638	3.1926379999999996
BIFID UVULA	0.030302999999999997	3.0302999999999995
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.030302999999999997	3.0302999999999995
OROFACIAL CLEFT 11; OFC11	0.030302999999999997	3.0302999999999995
HOLOPROSENCEPHALY 3; HPE3	0.030302999999999997	3.0302999999999995
SPEECH-LANGUAGE DISORDER 1	0.02968256	2.9682560000000002
15Q13.3 MICRODELETION SYNDROME	0.02958285	2.958285
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.02954921	2.954921
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.02934275	2.934275
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.02934275	2.934275
CLEFT CHIN	0.027777800000000002	2.7777800000000004
OROFACIAL CLEFT 3	0.027777800000000002	2.7777800000000004
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	2.7777800000000004
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	2.7777800000000004
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	2.7777800000000004
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.027777800000000002	2.7777800000000004
CYANIDE, INABILITY TO SMELL	0.027777800000000002	2.7777800000000004
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	2.7777800000000004
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	2.7777800000000004
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	2.7777800000000004
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	2.7777800000000004
NASAL BONES, ABSENCE OF	0.027777800000000002	2.7777800000000004
MENKES DISEASE	0.027777800000000002	2.7777800000000004
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	2.7777800000000004
DWARFISM, LEVI TYPE	0.027777800000000002	2.7777800000000004
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	2.7777800000000004
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	2.7777800000000004
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	2.7777800000000004
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	2.7777800000000004
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	2.7777800000000004
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	2.7777800000000004
DIMPLES, FACIAL	0.027777800000000002	2.7777800000000004
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	2.7777800000000004
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	2.7777800000000004
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	2.7777800000000004
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	2.7777800000000004
XERODERMA PIGMENTOSUM	0.02477229	2.477229
FREEMAN-SHELDON SYNDROME	0.02256106	2.256106
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.02082942	2.082942
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.02021347	2.021347
TRISOMY 13	0.01999287	1.999287
ADNP SYNDROME	0.01950145	1.950145
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.01875885	1.875885
OROFACIODIGITAL SYNDROME TYPE 1	0.01853911	1.853911
22Q11.2 MICRODUPLICATION SYNDROME	0.01795172	1.795172
WIEDEMANN-STEINER SYNDROME; WDSTS	0.01757575	1.757575
KOOLEN-DE VRIES SYNDROME; KDVS	0.0174009	1.7400900000000001
MOTION SICKNESS	0.0172414	1.72414
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	1.72414
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	1.72414
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	1.72414
CARDIAC ARRHYTHMIA	0.0172414	1.72414
ALCOHOL DEPENDENCE	0.0172414	1.72414
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	1.72414
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	1.72414
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	1.72414
SICKLE CELL ANEMIA	0.0172414	1.72414
JUMPING FRENCHMAN OF MAINE	0.0172414	1.72414
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	1.72414
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	1.72414
CERVICAL RIB	0.0172414	1.72414
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	1.72414
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	1.72414
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	1.72414
MYOPATHY, CONGENITAL	0.0172414	1.72414
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	1.72414
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	1.72414
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	1.72414
RHEUMATOID ARTHRITIS	0.0172414	1.72414
TRANSSEXUALITY	0.0172414	1.72414
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	1.72414
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	1.72414
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	1.72414
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	1.72414
ERYTHERMALGIA, PRIMARY	0.0172414	1.72414
ENDOCARDIAL FIBROELASTOSIS	0.0172414	1.72414
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	1.72414
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	1.72414
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	1.72414
DIASTEMATOMYELIA	0.0172414	1.72414
269800 SENILE PLAQUE FORMATION	0.0172414	1.72414
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	1.72414
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	1.72414
MOSAIC TRISOMY 15	0.0172414	1.72414
SPASTIC PSEUDOSCLEROSIS	0.0172414	1.72414
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	1.72414
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	1.72414
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	1.72414
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	1.72414
THUMBS, CONGENITAL CLASPED	0.0172414	1.72414
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	1.72414
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	1.72414
PALMOMENTAL REFLEX	0.0172414	1.72414
ANDROSTENONE, ABILITY TO SMELL	0.0172414	1.72414
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	1.72414
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	1.72414
CONGENITAL TRACHEAL STENOSIS	0.0172414	1.72414
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	1.72414
WITTEVEEN-KOLK SYNDROME	0.0172307	1.72307
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.0168578	1.6857799999999998
ZLOTOGORA-OGUR SYNDROME	0.0168212	1.68212
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.01681231	1.6812310000000001
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.01650699	1.650699
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.0162373	1.62373
SHORT SYNDROME	0.016005270000000002	1.6005270000000003
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.015957449999999998	1.5957449999999997
LAMELLAR ICHTHYOSIS	0.015957449999999998	1.5957449999999997
ZTTK SYNDROME; ZTTKS	0.015876249999999998	1.5876249999999998
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.01580656	1.580656
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.015323509999999999	1.5323509999999998
SMITH-MAGENIS SYNDROME	0.015028910000000001	1.5028910000000002
TRISOMY 20P	0.014990820000000002	1.4990820000000002
3C SYNDROME	0.0149292	1.49292
SIMPSON-GOLABI-BEHMEL SYNDROME	0.0149292	1.49292
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.014870770000000002	1.4870770000000002
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.0148038	1.48038
RECESSIVE X-LINKED ICHTHYOSIS	0.01468198	1.4681980000000001
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.01449972	1.449972
PELIZAEUS-MERZBACHER DISEASE	0.0143748	1.43748
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.014218340000000001	1.421834
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.01421257	1.421257
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.01406168	1.406168
ACROOSTEOLYSIS DOMINANT TYPE	0.01403461	1.4034609999999998
AYME-GRIPP SYNDROME; AYGRP	0.014014050000000002	1.4014050000000002
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.013846470000000001	1.3846470000000002
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.013780299999999999	1.3780299999999999
MOSAIC MONOSOMY X	0.01375974	1.375974
TURNER SYNDROME	0.01375974	1.375974
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.01375974	1.375974
MONOSOMY X	0.01375974	1.375974
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.01367279	1.3672790000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.0135353	1.3535300000000001
KLEEFSTRA SYNDROME	0.01346101	1.346101
OCULOMAXILLOFACIAL DYSOSTOSIS	0.013410499999999999	1.3410499999999999
ASPARTYLGLUCOSAMINURIA	0.01340553	1.340553
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.01338088	1.338088
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.013305820000000001	1.3305820000000002
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.013305820000000001	1.3305820000000002
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.013305820000000001	1.3305820000000002
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.01328635	1.328635
ROTHMUND-THOMSON SYNDROME	0.01319354	1.319354
3Q29 MICRODUPLICATION SYNDROME	0.013083359999999999	1.308336
GABRIELE-DE VRIES SYNDROME	0.013039340000000002	1.3039340000000001
17Q24.2 MICRODELETION SYNDROME	0.012967860000000001	1.2967860000000002
CRI-DU-CHAT SYNDROME	0.01292036	1.292036
METACHROMATIC LEUKODYSTROPHY	0.01285735	1.285735
NASU-HAKOLA DISEASE	0.01285735	1.285735
NEURONAL CEROID LIPOFUSCINOSIS	0.01285735	1.285735
CEREBROTENDINOUS XANTHOMATOSIS	0.01285735	1.285735
KABUKI SYNDROME 1	0.01284326	1.284326
COFFIN-SIRIS SYNDROME	0.01284326	1.284326
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.012816939999999999	1.2816939999999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.01271723	1.271723
PHELAN-MCDERMID SYNDROME	0.01268026	1.268026
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.01268026	1.268026
ADULT SYNDROME	0.01260411	1.260411
CRANIOFRONTONASAL SYNDROME; CFNS	0.01255503	1.255503
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.01254618	1.254618
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01254618	1.254618
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.012520670000000001	1.252067
21Q22.11Q22.12 MICRODELETION SYNDROME	0.012425640000000002	1.2425640000000002
OROFACIODIGITAL SYNDROME I; OFD1	0.012404140000000001	1.2404140000000001
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.012398880000000001	1.239888
DISTAL MONOSOMY 6P	0.01238922	1.2389219999999999
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.012345710000000001	1.234571
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.012345710000000001	1.234571
15Q26 OVERGROWTH SYNDROME	0.0123167	1.23167
GERMAN SYNDROME	0.0123167	1.23167
DISTAL MONOSOMY 15Q	0.012207550000000001	1.220755
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.01219665	1.219665
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.01219665	1.219665
WORSTER-DROUGHT SYNDROME	0.01219665	1.219665
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01219665	1.219665
MUSCLE-EYE-BRAIN DISEASE	0.01219665	1.219665
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.01219479	1.219479
ERYTHROKERATODERMIA VARIABILIS	0.01215692	1.215692
4Q21 MICRODELETION SYNDROME	0.012149120000000001	1.2149120000000002
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.012135030000000002	1.2135030000000002
BRANCHIO-OCULO-FACIAL SYNDROME	0.012076600000000002	1.2076600000000002
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.012049410000000002	1.2049410000000003
8Q21.11 MICRODELETION SYNDROME	0.012049410000000002	1.2049410000000003
DISTAL MONOSOMY 10Q	0.01203717	1.203717
AICARDI-GOUTIÈRES SYNDROME	0.01201026	1.201026
REFSUM DISEASE	0.01201026	1.201026
BARDET-BIEDL SYNDROME 1; BBS1	0.011969220000000001	1.196922
BARDET-BIEDL SYNDROME	0.011869510000000002	1.186951
BRANCHIOOCULOFACIAL SYNDROME	0.01186774	1.186774
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01182938	1.182938
CORNELIA DE LANGE SYNDROME	0.011735340000000002	1.1735340000000003
GOLDENHAR SYNDROME	0.011687840000000001	1.168784
GAPO SYNDROME; GAPOS	0.01166646	1.166646
AARSKOG-SCOTT SYNDROME	0.011596780000000001	1.159678
MONOSOMY 18P	0.011562230000000001	1.1562230000000002
SMITH-MAGENIS SYNDROME; SMS	0.011559690000000001	1.155969
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.011559690000000001	1.155969
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.01150077	1.150077
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.011472300000000001	1.1472300000000002
MOWAT-WILSON SYNDROME; MOWS	0.011443640000000001	1.1443640000000002
CHROMOSOME 10Q26 DELETION SYNDROME	0.01140291	1.140291
TONNE-KALSCHEUER SYNDROME; TOKAS	0.01140291	1.140291
COFFIN-LOWRY SYNDROME	0.011341180000000001	1.1341180000000002
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.011341180000000001	1.1341180000000002
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.011337710000000003	1.1337710000000003
KOOLEN-DE VRIES SYNDROME	0.01128794	1.128794
COFFIN-SIRIS SYNDROME 1; CSS1	0.01125017	1.125017
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.011234290000000001	1.123429
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.011189600000000001	1.1189600000000002
WIEDEMANN-STEINER SYNDROME	0.01116281	1.116281
FOUNTAIN SYNDROME	0.011101080000000001	1.110108
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.01103136	1.1031360000000001
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.01103136	1.1031360000000001
MUCOPOLYSACCHARIDOSIS TYPE 2	0.011014320000000001	1.1014320000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.01099517	1.099517
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.010954440000000001	1.095444
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010954440000000001	1.095444
CRANIOFRONTONASAL DYSPLASIA	0.010931650000000001	1.0931650000000002
PHENYLKETONURIA	0.01087431	1.087431
GALLOWAY-MOWAT SYNDROME	0.010811600000000001	1.0811600000000001
TETRASOMY X	0.010811600000000001	1.0811600000000001
MARSHALL SYNDROME	0.01074998	1.074998
DISTAL MONOSOMY 9P	0.01074998	1.074998
VASCULAR EHLERS-DANLOS SYNDROME	0.010708210000000001	1.070821
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.01067734	1.067734
ALSTROM SYNDROME; ALMS	0.01067734	1.067734
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.01067734	1.067734
SEVERE COMBINED IMMUNODEFICIENCY	0.01067734	1.067734
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.01067734	1.067734
HOLMES-GANG SYNDROME	0.010658460000000002	1.065846
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.01063947	1.063947
JUVENILE DERMATOMYOSITIS	0.01063947	1.063947
SÉZARY SYNDROME	0.01063947	1.063947
AUTOSOMAL RECESSIVE HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.01063947	1.063947
190360 TRICHODYSPLASIA-XERODERMA	0.01063947	1.063947
CLASSIC MYCOSIS FUNGOIDES	0.01063947	1.063947
OMENN SYNDROME	0.01063947	1.063947
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.01063947	1.063947
TRICHODYSPLASIA-XERODERMA SYNDROME	0.01063947	1.063947
TRANSGREDIENS ET PROGREDIENS PALMOPLANTAR KERATODERMA	0.01063947	1.063947
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.01063947	1.063947
ACRODERMATITIS ENTEROPATHICA	0.01063947	1.063947
MONOSOMY 9P	0.01059039	1.059039
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.01059039	1.059039
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.010567130000000001	1.056713
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.01055252	1.0552519999999999
FLOATING-HARBOR SYNDROME	0.01051165	1.0511650000000001
SIALIDOSIS TYPE 1	0.01051165	1.0511650000000001
CARDIOFACIOCUTANEOUS SYNDROME	0.010494090000000001	1.049409
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.01048318	1.048318
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.01048318	1.048318
RETT SYNDROME; RTT	0.01048318	1.048318
RETT SYNDROME	0.01048318	1.048318
ADIPOSIS DOLOROSA	0.01044531	1.0445309999999999
MENKES DISEASE	0.01044531	1.0445309999999999
COHEN SYNDROME	0.010352060000000001	1.035206
RECOMBINANT 8 SYNDROME	0.01030279	1.030279
DUBOWITZ SYNDROME	0.01020649	1.0206490000000001
MENTAL RETARDATION, X-LINKED 104; MRX104	0.010200480000000001	1.020048
PITT-HOPKINS SYNDROME	0.010200480000000001	1.020048
NEURALGIC AMYOTROPHY	0.010170390000000001	1.017039
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.010140600000000001	1.0140600000000002
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.010140600000000001	1.0140600000000002
CHROMOSOME 16P13.2 DELETION SYNDROME	0.010140600000000001	1.0140600000000002
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.010111960000000001	1.0111960000000002
TRISOMY XQ28	0.010111960000000001	1.0111960000000002
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.010111960000000001	1.0111960000000002
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.010111960000000001	1.0111960000000002
2Q32Q33 MICRODELETION SYNDROME	0.01007253	1.007253
GLASS SYNDROME	0.01007253	1.007253
NEUROFIBROMATOSIS TYPE 1	0.01006446	1.0064460000000002
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.01006446	1.0064460000000002
MICROPHTHALMIA, LENZ TYPE	0.01006446	1.0064460000000002
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.01006446	1.0064460000000002
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.01006446	1.0064460000000002
CAMURATI-ENGELMANN DISEASE	0.01006446	1.0064460000000002
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.01006446	1.0064460000000002
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.010042240000000001	1.004224
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.010040890000000002	1.0040890000000002
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.01004089	1.004089
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.01004089	1.004089
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.01004089	1.004089
RAYNAUD-CLAES SYNDROME; MRXSRC	0.01004089	1.004089
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.0100388	1.00388
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0100388	1.00388
OGDEN SYNDROME; OGDNS	0.00994253	0.9942529999999999
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.009919970000000002	0.9919970000000002
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.00990643	0.990643
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.00990466	0.990466
GABRIELE-DE VRIES SYNDROME; GADEVS	0.00988265	0.988265
MONILETHRIX	0.00982248	0.982248
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00982248	0.982248
NON-DISTAL TRISOMY 13Q	0.00982248	0.982248
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.009820260000000003	0.9820260000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.0098044	0.98044
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00978461	0.9784609999999999
DK1-CDG	0.00978461	0.9784609999999999
KERATODERMA HEREDITARIUM MUTILANS	0.00977752	0.977752
PITT-HOPKINS-LIKE SYNDROME	0.009753290000000001	0.9753290000000001
16P13.2 MICRODELETION SYNDROME	0.009753290000000001	0.9753290000000001
15Q14 MICRODELETION SYNDROME	0.00970098	0.970098
FOCAL DERMAL HYPOPLASIA	0.00967159	0.9671590000000001
MULTIPLE CARBOXYLASE DEFICIENCY	0.00967159	0.9671590000000001
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00967159	0.9671590000000001
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.00966934	0.9669340000000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.00966934	0.9669340000000001
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00966934	0.9669340000000001
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.009664559999999999	0.9664559999999999
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.009664559999999999	0.9664559999999999
CENTRAL CONGENITAL HYPOTHYROIDISM	0.009663109999999999	0.9663109999999999
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00963214	0.9632140000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.00963147	0.963147
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.00963147	0.963147
PRIMROSE SYNDROME; PRIMS	0.009626790000000001	0.9626790000000002
14Q12 MICRODELETION SYNDROME	0.009611890000000001	0.9611890000000002
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00959748	0.959748
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.00959109	0.959109
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.009585100000000001	0.9585100000000001
19Q13.11 MICRODELETION SYNDROME	0.00955718	0.9557180000000001
ABLEPHARON MACROSTOMIA SYNDROME	0.00955718	0.9557180000000001
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00954284	0.954284
FUMARASE DEFICIENCY; FMRD	0.00953613	0.953613
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.009532660000000002	0.9532660000000002
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.009524930000000001	0.952493
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.009524930000000001	0.952493
CANAVAN DISEASE	0.00947743	0.947743
3MC SYNDROME 2	0.00946459	0.946459
WOLF-HIRSCHHORN SYNDROME	0.00946459	0.946459
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00943827	0.9438270000000001
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.00943827	0.9438270000000001
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00943827	0.9438270000000001
CHROMOSOME 1P36 DELETION SYNDROME	0.009438269999999999	0.9438269999999999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.009371790000000001	0.9371790000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.009371790000000001	0.9371790000000001
DISTAL MONOSOMY 3P	0.00934454	0.934454
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.00932429	0.9324290000000001
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.00932429	0.9324290000000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.00932429	0.9324290000000001
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.00931648	0.931648
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.00922496	0.9224960000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.009198169999999999	0.9198169999999999
DESANTO-SHINAWI SYNDROME	0.00915067	0.915067
7Q11.23 MICRODUPLICATION SYNDROME	0.00915067	0.915067
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00914326	0.914326
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00914326	0.914326
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0091266	0.91266
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0091266	0.91266
VELO-FACIAL-SKELETAL SYNDROME	0.0091266	0.91266
SYNDROMIC DIARRHEA	0.00908873	0.9088729999999999
MOEBIUS SYNDROME; MBS	0.00906672	0.906672
MYOCLONIC EPILEPSY OF INFANCY	0.009049680000000001	0.9049680000000001
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.009049680000000001	0.9049680000000001
MYOCLONIC-ASTASTIC EPILEPSY	0.009049680000000001	0.9049680000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.009049680000000001	0.9049680000000001
RING CHROMOSOME 1 SYNDROME	0.00898428	0.8984280000000001
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.008967010000000001	0.8967010000000001
CEDNIK SYNDROME	0.008967010000000001	0.8967010000000001
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.00888957	0.888957
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.008814840000000001	0.881484
FLYNN-AIRD SYNDROME	0.008814840000000001	0.881484
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.008795960000000002	0.8795960000000002
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.008795960000000002	0.8795960000000002
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.008795960000000002	0.8795960000000002
OROFACIODIGITAL SYNDROME IX; OFD9	0.008785339999999999	0.8785339999999999
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.008785339999999999	0.8785339999999999
2P15P16.1 MICRODELETION SYNDROME	0.00875685	0.875685
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.00875685	0.875685
CHAND SYNDROME	0.00874747	0.874747
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.008726910000000001	0.8726910000000001
RECOMBINANT CHROMOSOME 8 SYNDROME	0.00867941	0.8679410000000001
BARBER-SAY SYNDROME; BBRSAY	0.00864154	0.864154
PROLIDASE DEFICIENCY	0.00864154	0.864154
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00860874	0.860874
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.00860197	0.8601970000000001
OCULOCEREBROCUTANEOUS SYNDROME	0.00857602	0.857602
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00854701	0.854701
TYROSINEMIA TYPE 2	0.00854701	0.854701
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00854701	0.854701
BETA-UREIDOPROPIONASE DEFICIENCY	0.00854701	0.854701
TOLUENE EMBRYOPATHY	0.00854701	0.854701
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.00854701	0.854701
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.00854701	0.854701
WHIM SYNDROME	0.00854701	0.854701
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00854701	0.854701
FRAGILE X SYNDROME	0.00854701	0.854701
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00854701	0.854701
ISOLATED CEREBELLAR AGENESIS	0.00854701	0.854701
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00854701	0.854701
ATAXIA-PANCYTOPENIA SYNDROME	0.00854701	0.854701
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00854701	0.854701
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.00854701	0.854701
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00854701	0.854701
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.00854701	0.854701
ALOPECIA ANTIBODY DEFICIENCY	0.00854701	0.854701
TAKAYASU ARTERITIS	0.00854701	0.854701
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00854701	0.854701
VON HIPPEL-LINDAU DISEASE	0.00854701	0.854701
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.00854701	0.854701
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.00854701	0.854701
HISTIDINEMIA	0.00854701	0.854701
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.00854701	0.854701
STURGE-WEBER SYNDROME	0.00854701	0.854701
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.00854701	0.854701
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00854701	0.854701
HISTIDINEMIA	0.00854701	0.854701
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00854701	0.854701
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00854701	0.854701
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.00854701	0.854701
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.00854701	0.854701
PYRIDOXINE-DEPENDENT EPILEPSY	0.00854701	0.854701
ALBINISM-DEAFNESS SYNDROME	0.00854701	0.854701
PRIMARY PROGRESSIVE FREEZING GAIT	0.00854701	0.854701
DYSLEXIA, SUSCEPTIBILITY TO, 1	0.00854701	0.854701
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00854701	0.854701
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00854701	0.854701
PENDRED SYNDROME	0.00854701	0.854701
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00854701	0.854701
ALZHEIMER DISEASE 10	0.00854701	0.854701
MENINGIOMA	0.00854701	0.854701
OTOFACIOCERVICAL SYNDROME	0.00854701	0.854701
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.00854701	0.854701
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.00854701	0.854701
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.00854701	0.854701
ARGININEMIA	0.00854701	0.854701
PSYCHOGENIC MOVEMENT DISORDERS	0.00854701	0.854701
CENTRAL BILATERAL MACROGYRIA	0.00854701	0.854701
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.00854701	0.854701
CONGENITAL RUBELLA SYNDROME	0.00854701	0.854701
ISOLATED GLYCEROL KINASE DEFICIENCY	0.00854701	0.854701
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00850903	0.8509030000000001
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.008449149999999999	0.8449149999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.008449149999999999	0.8449149999999999
LUSCAN-LUMISH SYNDROME; LLS	0.008449149999999999	0.8449149999999999
3Q29 MICRODELETION SYNDROME	0.008449149999999999	0.8449149999999999
NAGER SYNDROME	0.00841559	0.8415590000000001
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00838898	0.838898
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.00838898	0.838898
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.008383950000000001	0.8383950000000001
CORNELIA DE LANGE SYNDROME 3	0.00835542	0.835542
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.00834857	0.834857
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.008235840000000001	0.8235840000000001
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.008235840000000001	0.8235840000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.008235840000000001	0.8235840000000001
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.008235840000000001	0.8235840000000001
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.008235840000000001	0.8235840000000001
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.008235840000000001	0.8235840000000001
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.008235840000000001	0.8235840000000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.008235840000000001	0.8235840000000001
PITT-HOPKINS SYNDROME	0.008235840000000001	0.8235840000000001
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.008235840000000001	0.8235840000000001
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.008235840000000001	0.8235840000000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.008235840000000001	0.8235840000000001
COHEN-GIBSON SYNDROME; COGIS	0.008228520000000001	0.8228520000000001
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00822852	0.8228519999999999
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.008214309999999999	0.8214309999999999
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00820905	0.8209050000000001
COFFIN-SIRIS SYNDROME 8; CSS8	0.008209049999999999	0.8209049999999999
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.00815414	0.8154140000000001
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00815414	0.8154140000000001
PACHYONYCHIA CONGENITA	0.00815414	0.8154140000000001
HIDROTIC ECTODERMAL DYSPLASIA	0.00815414	0.8154140000000001
INCONTINENTIA PIGMENTI	0.00815414	0.8154140000000001
DEAFNESS-CRANIOFACIAL SYNDROME	0.008137479999999999	0.8137479999999999
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.008137479999999999	0.8137479999999999
8Q22.1 MICRODELETION SYNDROME	0.008137479999999999	0.8137479999999999
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.008137479999999999	0.8137479999999999
SCLEROSTEOSIS 1; SOST1	0.00812085	0.8120850000000001
9P13 MICRODELETION SYNDROME	0.00809961	0.809961
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00809961	0.809961
JUNG SYNDROME	0.00809961	0.809961
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.008092519999999999	0.8092519999999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.008077599999999999	0.8077599999999999
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.00806097	0.8060970000000001
OKAMOTO SYNDROME	0.008046850000000001	0.8046850000000001
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00803973	0.803973
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00803973	0.803973
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.00803973	0.803973
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00799935	0.7999350000000001
DEAFNESS-CRANIOFACIAL SYNDROME	0.00798659	0.798659
CHROMOSOME 1P35 DELETION SYNDROME	0.007967710000000001	0.7967710000000001
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.00795998	0.795998
GM2 GANGLIOSIDOSIS, AB VARIANT	0.00795998	0.795998
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.00795998	0.795998
FABRY DISEASE	0.00795998	0.795998
DRAVET SYNDROME	0.00795998	0.795998
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00795998	0.795998
NIEMANN-PICK DISEASE TYPE C	0.00795998	0.795998
22Q11.2 DELETION SYNDROME	0.00794714	0.794714
SMITH-LEMLI-OPITZ SYNDROME	0.00794714	0.794714
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.00794714	0.794714
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00794714	0.794714
HALLERMANN-STREIFF SYNDROME; HSS	0.00794002	0.7940020000000001
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00794002	0.7940020000000001
JOHNSON NEUROECTODERMAL SYNDROME	0.00793293	0.7932929999999999
PIERPONT SYNDROME	0.007907830000000001	0.7907830000000001
OTOPALATODIGITAL SYNDROME TYPE 1	0.00789964	0.7899639999999999
DISTAL MONOSOMY 10P	0.00789964	0.7899639999999999
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00789964	0.7899639999999999
ACROCALLOSAL SYNDROME; ACLS	0.00789964	0.7899639999999999
MENTAL RETARDATION, X-LINKED 102	0.007880169999999999	0.7880169999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00785562	0.7855620000000001
RUBINSTEIN-TAYBI SYNDROME	0.007841210000000001	0.7841210000000001
NEONATAL ADRENOLEUKODYSTROPHY	0.00783993	0.783993
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.007827	0.7827000000000001
MICROPHTHALMIA, SYNDROMIC 1	0.00782174	0.782174
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.007806840000000001	0.780684
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.007806840000000001	0.780684
SALT-AND-PEPPER SYNDROME	0.007806840000000001	0.780684
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.007806840000000001	0.780684
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.007806840000000001	0.780684
AMISH INFANTILE EPILEPSY SYNDROME	0.007806840000000001	0.780684
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.007806840000000001	0.780684
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.007806840000000001	0.780684
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.007806840000000001	0.780684
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.007806840000000001	0.780684
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.007806840000000001	0.780684
CHRISTIANSON SYNDROME	0.007806840000000001	0.780684
AICARDI-GOUTIERES SYNDROME 7	0.007806840000000001	0.780684
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.007806840000000001	0.780684
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.007806840000000001	0.780684
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.007806840000000001	0.780684
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.007806840000000001	0.780684
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.007806840000000001	0.780684
CHILDHOOD DISINTEGRATIVE DISORDER	0.007806840000000001	0.780684
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.0077962199999999995	0.7796219999999999
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.0077962199999999995	0.7796219999999999
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.0077962199999999995	0.7796219999999999
BRITTLE CORNEA SYNDROME	0.0077962199999999995	0.7796219999999999
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.00778005	0.7780050000000001
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00775835	0.7758349999999999
EEC SYNDROME	0.00775835	0.7758349999999999
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00775835	0.7758349999999999
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.00775835	0.7758349999999999
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.00773779	0.773779
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00773779	0.773779
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.00773779	0.773779
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00773779	0.773779
HSD10 DISEASE	0.00773255	0.773255
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00773255	0.773255
DISTAL TRISOMY 6P	0.00769992	0.769992
DERMOODONTODYSPLASIA	0.00769992	0.769992
POPOV-CHANG SYNDROME; POPCHAS	0.00769992	0.769992
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00769992	0.769992
BETA-THALASSEMIA MAJOR	0.00769029	0.769029
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00769029	0.769029
JUVENILE PAGET DISEASE	0.00769029	0.769029
FUCOSIDOSIS	0.00769029	0.769029
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00769029	0.769029
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.00769029	0.769029
BUSCHKE-OLLENDORFF SYNDROME	0.00769029	0.769029
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0076739500000000006	0.767395
XFE PROGEROID SYNDROME; XFEPS	0.00765242	0.765242
AGEL AMYLOIDOSIS	0.00765242	0.765242
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.00765242	0.765242
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.00765242	0.765242
PLAGUE	0.00765242	0.765242
ALG11-CDG	0.00765242	0.765242
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.00765242	0.765242
BRESEK SYNDROME	0.00764533	0.764533
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00763322	0.763322
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.00763322	0.763322
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.00763322	0.763322
48,XYYY SYNDROME	0.00763322	0.763322
TRISOMY 17P	0.00749995	0.749995
FRONTONASAL DYSPLASIA 2; FND2	0.0074582599999999995	0.745826
RING CHROMOSOME 13 SYNDROME	0.0074582599999999995	0.745826
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00741933	0.741933
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.00739274	0.739274
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00739274	0.739274
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00739274	0.739274
MEND SYNDROME	0.00735184	0.7351840000000001
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.0072661900000000005	0.726619
HAMAMY SYNDROME; HMMS	0.007264100000000001	0.7264100000000001
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0072394	0.72394
20Q11.2 MICRODUPLICATION SYNDROME	0.0072394	0.72394
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.0071919	0.71919
NON-DISTAL MONOSOMY 10Q	0.00717923	0.717923
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00717923	0.717923
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00716196	0.716196
PELGER-HUET ANOMALY; PHA	0.00716196	0.716196
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00716196	0.716196
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.00716196	0.716196
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00716196	0.716196
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.00716196	0.716196
FOIX-CHAVANY-MARIE SYNDROME	0.0071461400000000005	0.7146140000000001
TRICHOTHIODYSTROPHY	0.00712409	0.712409
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00712409	0.712409
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00711935	0.711935
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00701964	0.7019639999999999
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.00701964	0.7019639999999999
GAPO SYNDROME	0.0070110699999999995	0.7011069999999999
MONOSOMY 22Q13.3	0.0069518	0.69518
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.0069518	0.69518
19P13.3 MICRODUPLICATION SYNDROME	0.006924930000000001	0.6924930000000001
3P25.3 MICRODELETION SYNDROME	0.006924930000000001	0.6924930000000001
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.00691052	0.691052
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.0068665	0.68665
TRISOMY 5P	0.0068644100000000005	0.6864410000000001
MELAS	0.0068644100000000005	0.6864410000000001
FETAL ALCOHOL SYNDROME	0.00683797	0.683797
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.006819	0.6819000000000001
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.006819	0.6819000000000001
DYSOSTEOSCLEROSIS	0.006816910000000001	0.681691
ISOLATED KLIPPEL-FEIL SYNDROME	0.00679047	0.679047
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00673204	0.673204
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00673204	0.673204
NOONAN SYNDROME 6; NS6	0.006663570000000001	0.6663570000000001
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.006663570000000001	0.6663570000000001
AL KAISSI SYNDROME; ALKAS	0.006663570000000001	0.6663570000000001
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.006663570000000001	0.6663570000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.006663570000000001	0.6663570000000001
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.0066441	0.66441
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.0066441	0.66441
FRAXE INTELLECTUAL DISABILITY	0.0066441	0.66441
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.0066441	0.66441
HYPERPROLINEMIA, TYPE I	0.0066441	0.66441
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.0066441	0.66441
CK SYNDROME	0.0066441	0.66441
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.0066441	0.66441
ADENYLOSUCCINASE DEFICIENCY	0.0066441	0.66441
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.0066441	0.66441
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.0066441	0.66441
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0066441	0.66441
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.0066441	0.66441
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0066441	0.66441
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0066441	0.66441
11P15.4 MICRODUPLICATION SYNDROME	0.0066441	0.66441
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.0066441	0.66441
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.0066441	0.66441
1P21.3 MICRODELETION SYNDROME	0.0066441	0.66441
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00663733	0.663733
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.00663733	0.663733
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00661054	0.661054
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.0065789	0.6578900000000001
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00654439	0.654439
DUPLICATION/INVERSION 15Q11	0.00654439	0.654439
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00654439	0.654439
ALG13-CDG	0.006543520000000001	0.654352
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00651083	0.651083
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00651083	0.651083
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00646914	0.646914
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.00646914	0.646914
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.006450260000000001	0.6450260000000001
HALL-RIGGS SYNDROME	0.006450260000000001	0.6450260000000001
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.006450260000000001	0.6450260000000001
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.006450260000000001	0.6450260000000001
TEMPLE-BARAITSER SYNDROME	0.006450260000000001	0.6450260000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.006450260000000001	0.6450260000000001
NOONAN SYNDROME 7; NS7	0.00644381	0.644381
NON-DISTAL TRISOMY 10Q	0.00644381	0.644381
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.00642347	0.642347
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00640926	0.640926
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00640926	0.640926
TREACHER-COLLINS SYNDROME	0.00638219	0.638219
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00638219	0.638219
OPITZ G/BBB SYNDROME	0.00638219	0.638219
6Q25 MICRODELETION SYNDROME	0.00638219	0.638219
ROBERTS SYNDROME; RBS	0.00638219	0.638219
GENITOPALATOCARDIAC SYNDROME	0.00638219	0.638219
HYPERTELORISM, TEEBI TYPE	0.00632376	0.632376
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00632376	0.632376
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.00632376	0.632376
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00632376	0.632376
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00632376	0.632376
HYPERTELORISM, TEEBI TYPE; TBHS	0.00632376	0.632376
JACOBSEN SYNDROME	0.00632376	0.632376
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00632376	0.632376
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00632231	0.632231
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.00630955	0.6309549999999999
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.00630955	0.6309549999999999
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.00630429	0.630429
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.00630429	0.630429
JOUBERT SYNDROME 1	0.00630429	0.630429
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.006290670000000001	0.629067
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.006290670000000001	0.629067
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.006290670000000001	0.629067
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.006290670000000001	0.629067
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.006290670000000001	0.629067
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.006290670000000001	0.629067
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.006290670000000001	0.629067
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.006290670000000001	0.629067
15Q24 MICRODELETION SYNDROME	0.0062762600000000005	0.627626
WILLIAMS SYNDROME	0.00627498	0.627498
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.00626388	0.6263880000000001
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.00626388	0.6263880000000001
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00626388	0.6263880000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00626388	0.6263880000000001
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00626388	0.6263880000000001
TRISOMY 18	0.00626214	0.626214
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00626214	0.626214
FRIED SYNDROME	0.00625679	0.625679
RICHARDS-RUNDLE SYNDROME; RRNS	0.00625679	0.625679
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.00625679	0.625679
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00625679	0.625679
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.00625679	0.625679
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00625679	0.625679
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.0062163800000000005	0.621638
COFFIN-SIRIS SYNDROME 7; CSS7	0.0062163800000000005	0.621638
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.0062151	0.62151
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.0062151	0.62151
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.0062151	0.62151
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0062151	0.62151
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0062151	0.62151
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.0062151	0.62151
RING CHROMOSOME 22 SYNDROME	0.0062151	0.62151
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.0062151	0.62151
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.0062151	0.62151
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.0062151	0.62151
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.0062151	0.62151
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.0062151	0.62151
ASPARTYLGLUCOSAMINURIA; AGU	0.0062151	0.62151
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.0062151	0.62151
KEIPERT SYNDROME	0.00620371	0.620371
HOLOPROSENCEPHALY	0.00620371	0.620371
CORNEODERMATOOSSEOUS SYNDROME	0.00617284	0.6172839999999999
EPILEPSY-TELANGIECTASIA SYNDROME	0.00617284	0.6172839999999999
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.00617284	0.6172839999999999
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.00617284	0.6172839999999999
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00617284	0.6172839999999999
INCISORS, FUSED MANDIBULAR	0.00617284	0.6172839999999999
FAMILIAL TUMORAL CALCINOSIS	0.00617284	0.6172839999999999
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	0.00617284	0.6172839999999999
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00617284	0.6172839999999999
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.00617284	0.6172839999999999
JABERI-ELAHI SYNDROME; JABELS	0.00617284	0.6172839999999999
SPLIT LOWER LIP	0.00617284	0.6172839999999999
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00617284	0.6172839999999999
TEETH, ODD SHAPES OFLOBODONTIA, INCLUDED	0.00617284	0.6172839999999999
STÜVE-WIEDEMANN SYNDROME	0.00617284	0.6172839999999999
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.00617284	0.6172839999999999
ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE	0.00617284	0.6172839999999999
ISOLATED HEMIHYPERPLASIA	0.00617284	0.6172839999999999
CANINE TEETH, ABSENCE OF UPPER PERMANENT	0.00617284	0.6172839999999999
CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH	0.00617284	0.6172839999999999
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00617284	0.6172839999999999
HEART-HAND SYNDROME TYPE 2	0.00617284	0.6172839999999999
PREMATURE OVARIAN FAILURE 2B	0.00617284	0.6172839999999999
SAGLIKER SYNDROME	0.00617284	0.6172839999999999
LEGG-CALVÉ-PERTHES DISEASE	0.00617284	0.6172839999999999
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.00617284	0.6172839999999999
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00617284	0.6172839999999999
PARAMOLAR TUBERCLE OF BOLK	0.00617284	0.6172839999999999
PRIMARY HYPEROXALURIA TYPE 1	0.00617284	0.6172839999999999
IRIDOGONIODYSGENESIS, TYPE 2	0.00617284	0.6172839999999999
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00617284	0.6172839999999999
17Q21.31 MICRODUPLICATION SYNDROME	0.00617284	0.6172839999999999
HYPOPHOSPHATASIA	0.00617284	0.6172839999999999
TOOTH SIZE	0.00617284	0.6172839999999999
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00617284	0.6172839999999999
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00617284	0.6172839999999999
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.00617284	0.6172839999999999
125300 DENS IN DENTE AND PALATAL INVAGINATIONS	0.00617284	0.6172839999999999
OSTEOGENESIS IMPERFECTA, TYPE V	0.00617284	0.6172839999999999
TEETH, FUSED	0.00617284	0.6172839999999999
DENS EVAGINATUS	0.00617284	0.6172839999999999
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.00617284	0.6172839999999999
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00617284	0.6172839999999999
BANGSTAD SYNDROME	0.00617284	0.6172839999999999
MOLAR I REINCLUSION	0.00617284	0.6172839999999999
MULTIPLE OSTEOCHONDROMAS	0.00617284	0.6172839999999999
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.00617284	0.6172839999999999
HYPOPHOSPHATASIA, INFANTILE	0.00617284	0.6172839999999999
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00617284	0.6172839999999999
ERYTHEMA OF ACRAL REGIONS	0.00617284	0.6172839999999999
BARDET-BIEDL SYNDROME 4; BBS4	0.00617284	0.6172839999999999
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.00617284	0.6172839999999999
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00617284	0.6172839999999999
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00614209	0.614209
MOSAIC TRISOMY 14	0.00614209	0.614209
TEEBI-SHALTOUT SYNDROME; TBSH	0.00614209	0.614209
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00614209	0.614209
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00614209	0.614209
ORAL EROSIVE LICHEN	0.00613497	0.613497
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.00613497	0.613497
TANGIER DISEASE	0.00613497	0.613497
DERMOODONTODYSPLASIA	0.00613497	0.613497
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00613497	0.613497
BLAU SYNDROME	0.00613497	0.613497
RARE CUTANEOUS LUPUS ERYTHEMATOSUS	0.00613497	0.613497
XERODERMA PIGMENTOSUM VARIANT	0.00613497	0.613497
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00613497	0.613497
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00613497	0.613497
SHEEHAN SYNDROME	0.00613497	0.613497
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00613497	0.613497
DERMATITIS, ATOPIC	0.00613497	0.613497
TOOTH AGENESIS, SELECTIVE, 8; STHAG8	0.00613497	0.613497
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00613497	0.613497
AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3; PLCA3	0.00613497	0.613497
TANGIER DISEASE; TGD	0.00613497	0.613497
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00613497	0.613497
DERMATOMYOSITIS	0.00613497	0.613497
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00613497	0.613497
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00613497	0.613497
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00613497	0.613497
257960 OCULOTRICHODYSPLASIA; OTD	0.00613497	0.613497
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.00613497	0.613497
RABSON-MENDENHALL SYNDROME	0.00613497	0.613497
AICARDI-GOUTIERES SYNDROME 5	0.00613497	0.613497
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00613497	0.613497
HELIX SYNDROME; HELIX	0.00613497	0.613497
SCLERODERMA	0.00613497	0.613497
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.00613497	0.613497
ANONYCHIA WITH FLEXURAL PIGMENTATION	0.00613497	0.613497
AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1	0.00613497	0.613497
CRANIOECTODERMAL DYSPLASIA 3	0.00613497	0.613497
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.00613497	0.613497
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.00613497	0.613497
ADDISON DISEASE	0.00613497	0.613497
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00613497	0.613497
ACQUIRED ICHTHYOSIS	0.00613497	0.613497
SJÖGREN-LARSSON SYNDROME	0.00613497	0.613497
COMPLEX REGIONAL PAIN SYNDROME	0.00613497	0.613497
IMMUNODEFICIENCY 55; IMD55	0.00613497	0.613497
ATOPIC KERATOCONJUNCTIVITIS	0.00613497	0.613497
PEELING SKIN SYNDROME	0.00613497	0.613497
PEROXISOME BIOGENESIS DISORDER 14B	0.00613497	0.613497
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.00613497	0.613497
KERATOSIS PILARIS ATROPHICANS	0.00613497	0.613497
AMELO-ONYCHO-HYPOHIDROTIC SYNDROME	0.00613497	0.613497
MYXEDEMA	0.00613497	0.613497
ECTODERMAL DYSPLASIA SYNDROME	0.00613497	0.613497
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00613497	0.613497
COCKAYNE SYNDROME A; CSA	0.00613497	0.613497
ACUTE ADRENAL INSUFFICIENCY	0.00613497	0.613497
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00613497	0.613497
FAMILIAL MELANOMA	0.00613497	0.613497
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.00613497	0.613497
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00613497	0.613497
SPINOCEREBELLAR ATAXIA TYPE 34	0.00613497	0.613497
CONGENITAL LETHAL ERYTHRODERMA	0.00613497	0.613497
ALPORT SYNDROME	0.00613497	0.613497
HURIEZ SYNDROME	0.00613497	0.613497
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.00613497	0.613497
NETHERTON SYNDROME	0.00613497	0.613497
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00613497	0.613497
TOOTH AGENESIS, SELECTIVE, 4	0.00613497	0.613497
HYDROXYKYNURENINURIA	0.00613497	0.613497
RENPENNING SYNDROME	0.00612788	0.612788
OCULOCEREBROCUTANEOUS SYNDROME	0.00612788	0.612788
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00612788	0.612788
DISTAL MONOSOMY 19P13.3	0.00612788	0.612788
ADAMS-OLIVER SYNDROME 1; AOS1	0.00612788	0.612788
PARC SYNDROME	0.00612788	0.612788
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.00611539	0.611539
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.006109000000000001	0.6109000000000001
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.006109000000000001	0.6109000000000001
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.006109000000000001	0.6109000000000001
BOHRING-OPITZ SYNDROME	0.00609459	0.6094590000000001
TARP SYNDROME	0.00609459	0.6094590000000001
SWEENEY-COX SYNDROME; SWCOS	0.00609459	0.6094590000000001
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.00606945	0.606945
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00606945	0.606945
GIANT CELL ARTERITIS	0.00606945	0.606945
THYMOMA	0.00606945	0.606945
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00606945	0.606945
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.006050570000000001	0.6050570000000001
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.006050570000000001	0.6050570000000001
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.00603616	0.6036159999999999
PALLISTER-KILLIAN SYNDROME	0.00603616	0.6036159999999999
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00603616	0.6036159999999999
MICROTRIPLICATION 11Q24.1	0.00603471	0.6034710000000001
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00602195	0.602195
KEUTEL SYNDROME	0.00602195	0.602195
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.00602195	0.602195
ADRENOLEUKODYSTROPHY	0.00602195	0.602195
BIOTINIDASE DEFICIENCY	0.00602195	0.602195
DYSKERATOSIS CONGENITA	0.00602195	0.602195
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.00602195	0.602195
PILI TORTI	0.00602195	0.602195
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00602195	0.602195
H SYNDROME	0.00602195	0.602195
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00602195	0.602195
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.0059825	0.59825
ACROCRANIOFACIAL DYSOSTOSIS	0.0059825	0.59825
ACROFRONTOFACIONASAL DYSOSTOSIS	0.0059825	0.59825
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.0059825	0.59825
CHARGE SYNDROME	0.0059825	0.59825
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0059825	0.59825
2Q31.1 MICRODELETION SYNDROME	0.0059825	0.59825
HARTSFIELD SYNDROME	0.0059825	0.59825
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.005935	0.5935
OTOPALATODIGITAL SYNDROME TYPE 2	0.005935	0.5935
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.00593372	0.593372
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00593372	0.593372
MUENKE SYNDROME	0.00587657	0.587657
CENANI-LENZ SYNDROME	0.00587657	0.587657
3MC SYNDROME	0.00587657	0.587657
14Q22Q23 MICRODELETION SYNDROME	0.00587657	0.587657
ALEXANDER DISEASE	0.00587529	0.587529
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.00587529	0.587529
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.00587529	0.587529
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.00587529	0.587529
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00587529	0.587529
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.00587529	0.587529
TAY-SACHS DISEASE	0.00582779	0.582779
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.00582779	0.582779
GAUCHER DISEASE	0.00582779	0.582779
CANAVAN DISEASE	0.00582779	0.582779
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00582779	0.582779
KRABBE DISEASE	0.00582779	0.582779
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.00582779	0.582779
ATYPICAL RETT SYNDROME	0.00582779	0.582779
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.00582779	0.582779
DYSOSTEOSCLEROSIS	0.00582779	0.582779
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.00582779	0.582779
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00582779	0.582779
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00582779	0.582779
HYPERTRYPTOPHANEMIA; HYPTRP	0.0057284599999999995	0.572846
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0057284599999999995	0.572846
3MC SYNDROME 3	0.0056949	0.56949
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0056949	0.56949
PETERS-PLUS SYNDROME; PTRPLS	0.0056949	0.56949
FANCONI ANEMIA	0.0056949	0.56949
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.0056949	0.56949
CHARGE SYNDROME	0.0056949	0.56949
CHIME SYNDROME	0.0056949	0.56949
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.00567445	0.567445
LAMB-SHAFFER SYNDROME	0.00567445	0.567445
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.00567445	0.567445
CLASSICAL EHLERS-DANLOS SYNDROME	0.00561428	0.561428
CARTILAGE-HAIR HYPOPLASIA	0.00561428	0.561428
ZELLWEGER SYNDROME	0.00561428	0.561428
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.0055544	0.55544
HYPERLYSINEMIA, TYPE I	0.0055544	0.55544
DUCHENNE MUSCULAR DYSTROPHY	0.0055544	0.55544
DYSTONIA 16; DYT16	0.0055544	0.55544
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.0055544	0.55544
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.0055544	0.55544
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.0055544	0.55544
SPINOCEREBELLAR ATAXIA TYPE 29	0.0055544	0.55544
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0055544	0.55544
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.0055544	0.55544
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.0055544	0.55544
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0055544	0.55544
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.005493619999999999	0.5493619999999999
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.005493619999999999	0.5493619999999999
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.005461140000000001	0.5461140000000001
1P36 DELETION SYNDROME	0.005461140000000001	0.5461140000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.005461140000000001	0.5461140000000001
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.005461140000000001	0.5461140000000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.005461140000000001	0.5461140000000001
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.005461140000000001	0.5461140000000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.005461140000000001	0.5461140000000001
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00545469	0.545469
SECKEL SYNDROME	0.00545469	0.545469
DUBOWITZ SYNDROME	0.00543435	0.543435
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00543435	0.543435
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00543435	0.543435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.005401260000000001	0.5401260000000001
MOSAIC TRISOMY 1	0.00539307	0.539307
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.00538685	0.5386850000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00538685	0.5386850000000001
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00538685	0.5386850000000001
GOLDBERG-SHPRINTZEN SYNDROME	0.00533464	0.5334639999999999
LATHOSTEROLOSIS	0.00533464	0.5334639999999999
HELSMOORTEL-VAN DER AA SYNDROME	0.00533464	0.5334639999999999
SCARF SYNDROME	0.00533464	0.5334639999999999
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00533464	0.5334639999999999
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00533464	0.5334639999999999
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00533464	0.5334639999999999
COFFIN-SIRIS SYNDROME 6; CSS6	0.00533319	0.533319
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00533319	0.533319
16P13.11 MICRODELETION SYNDROME	0.00533319	0.533319
MEIER-GORLIN SYNDROME 6; MGORS6	0.00533319	0.533319
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00533319	0.533319
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00533319	0.533319
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00527476	0.527476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.00527476	0.527476
MUCOLIPIDOSIS TYPE III	0.00527302	0.5273019999999999
ISOTRETINOIN SYNDROME	0.00527302	0.5273019999999999
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.00527302	0.5273019999999999
RHIZOMELIC SYNDROME, URBACH TYPE	0.00527302	0.5273019999999999
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00527302	0.5273019999999999
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.00527302	0.5273019999999999
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00527302	0.5273019999999999
16P11.2P12.2 MICRODELETION SYNDROME	0.00522726	0.522726
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00521459	0.521459
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00521459	0.521459
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00521459	0.521459
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.00521459	0.521459
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00521459	0.521459
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00521459	0.521459
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.00521459	0.521459
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.00521459	0.521459
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00516709	0.516709
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00516709	0.516709
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.00516709	0.516709
CYCLIC VOMITING SYNDROME	0.00516709	0.516709
THANATOPHORIC DYSPLASIA TYPE 2	0.00516709	0.516709
COWDEN SYNDROME	0.00516709	0.516709
CONGENITAL TOXOPLASMOSIS	0.00516709	0.516709
DISTAL TRISOMY 14Q	0.00516709	0.516709
BARDET-BIEDL SYNDROME 16; BBS16	0.00516709	0.516709
COWCHOCK SYNDROME; COWCK	0.00516709	0.516709
WAARDENBURG SYNDROME TYPE 1	0.00515297	0.515297
DUANE RETRACTION SYNDROME	0.00515297	0.515297
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00511988	0.511988
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00511988	0.511988
RENPENNING SYNDROME 1; RENS1	0.00510547	0.510547
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00510547	0.510547
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00510547	0.510547
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00510547	0.510547
CORNELIA DE LANGE SYNDROME 1	0.00509309	0.509309
HADZISELIMOVIC SYNDROME	0.00506145	0.5061450000000001
ALLAN-HERNDON-DUDLEY SYNDROME	0.00506145	0.5061450000000001
PONTINE TEGMENTAL CAP DYSPLASIA	0.00506145	0.5061450000000001
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.00506145	0.5061450000000001
COFFIN-SIRIS SYNDROME 5	0.00506145	0.5061450000000001
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.00506145	0.5061450000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.00506145	0.5061450000000001
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00504704	0.504704
DEAFNESS, X-LINKED 7; DFNX7	0.00504704	0.504704
OHDO SYNDROME	0.00504704	0.504704
EMANUEL SYNDROME	0.00504559	0.504559
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0050139500000000005	0.501395
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.0050139500000000005	0.501395
OPTIC ATROPHY 11; OPA11	0.0050139500000000005	0.501395
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.0050139500000000005	0.501395
YOU-HOOVER-FONG SYNDROME; YHFS	0.0050139500000000005	0.501395
OPTICOCOCHLEODENTATE DEGENERATION	0.0050139500000000005	0.501395
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0050139500000000005	0.501395
TRANSKETOLASE DEFICIENCY	0.0050139500000000005	0.501395
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.0050139500000000005	0.501395
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0050139500000000005	0.501395
CAREY-FINEMAN-ZITER SYNDROME	0.00499338	0.49933800000000006
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00499338	0.49933800000000006
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00499338	0.49933800000000006
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00499338	0.49933800000000006
AU-KLINE SYNDROME; AUKS	0.00499338	0.49933800000000006
ACROCRANIOFACIAL DYSOSTOSIS	0.00499338	0.49933800000000006
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00499338	0.49933800000000006
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.00498716	0.498716
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.00494588	0.49458799999999997
LATHOSTEROLOSIS	0.00488745	0.488745
MESOMELIA-SYNOSTOSES SYNDROME	0.00488745	0.488745
CHROMOSOME 9P DELETION SYNDROME	0.00485852	0.485852
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.00485852	0.485852
49,XXXYY SYNDROME	0.00485852	0.485852
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00485852	0.485852
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00485852	0.485852
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.00485852	0.485852
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.00485852	0.485852
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.00485852	0.485852
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00485852	0.485852
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00485852	0.485852
311450 PALLISTER W SYNDROME;;W SYNDROME	0.0047588100000000005	0.47588100000000005
MONOSOMY 5P	0.0047588100000000005	0.47588100000000005
15Q OVERGROWTH SYNDROME	0.0047588100000000005	0.47588100000000005
COG1-CDG	0.0047588100000000005	0.47588100000000005
HEREDITARY OROTIC ACIDURIA	0.0047588100000000005	0.47588100000000005
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.0047588100000000005	0.47588100000000005
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.0047588100000000005	0.47588100000000005
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.0047588100000000005	0.47588100000000005
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.0047588100000000005	0.47588100000000005
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0047588100000000005	0.47588100000000005
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.0047588100000000005	0.47588100000000005
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.0047588100000000005	0.47588100000000005
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.0047588100000000005	0.47588100000000005
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0047588100000000005	0.47588100000000005
CRANIOFACIAL DYSSYNOSTOSIS	0.0047588100000000005	0.47588100000000005
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0047588100000000005	0.47588100000000005
20P12.3 MICRODELETION SYNDROME	0.0047588100000000005	0.47588100000000005
MAN1B1-CDG	0.0047588100000000005	0.47588100000000005
RING CHROMOSOME 10 SYNDROME	0.0047588100000000005	0.47588100000000005
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.0047588100000000005	0.47588100000000005
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0047588100000000005	0.47588100000000005
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.0047588100000000005	0.47588100000000005
FRANK-TER HAAR SYNDROME	0.0047588100000000005	0.47588100000000005
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.0047588100000000005	0.47588100000000005
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0047588100000000005	0.47588100000000005
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.0047588100000000005	0.47588100000000005
ELSAHY-WATERS SYNDROME; ESWS	0.0047588100000000005	0.47588100000000005
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00473934	0.47393399999999997
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.00473934	0.47393399999999997
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00473934	0.47393399999999997
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.00473934	0.47393399999999997
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.00473934	0.47393399999999997
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.00473934	0.47393399999999997
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00473934	0.47393399999999997
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00473934	0.47393399999999997
SPINOCEREBELLAR ATAXIA TYPE 27	0.00473934	0.47393399999999997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.00473934	0.47393399999999997
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.00473934	0.47393399999999997
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00473934	0.47393399999999997
SPINOCEREBELLAR ATAXIA TYPE 10	0.00473934	0.47393399999999997
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00473934	0.47393399999999997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00473934	0.47393399999999997
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00473934	0.47393399999999997
WILSON DISEASE	0.00473934	0.47393399999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.00473934	0.47393399999999997
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.00473934	0.47393399999999997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.00473934	0.47393399999999997
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00473934	0.47393399999999997
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00473934	0.47393399999999997
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.00473934	0.47393399999999997
CITRULLINEMIA TYPE II	0.00473934	0.47393399999999997
2Q23.1 MICRODUPLICATION SYNDROME	0.00473934	0.47393399999999997
KUFOR-RAKEB SYNDROME	0.00473934	0.47393399999999997
GLYCINE ENCEPHALOPATHY; GCE	0.00473934	0.47393399999999997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00473934	0.47393399999999997
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.00473934	0.47393399999999997
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00473934	0.47393399999999997
X-LINKED ADRENOLEUKODYSTROPHY	0.00473934	0.47393399999999997
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00473934	0.47393399999999997
MENTAL RETARDATION, X-LINKED 99	0.00473934	0.47393399999999997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.00473934	0.47393399999999997
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00473934	0.47393399999999997
JAWAD SYNDROME	0.00473934	0.47393399999999997
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.00473934	0.47393399999999997
HUNTINGTON DISEASE-LIKE 1	0.00473934	0.47393399999999997
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00473934	0.47393399999999997
BRUNNER SYNDROME; BRNRS	0.00473934	0.47393399999999997
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.00473934	0.47393399999999997
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00473934	0.47393399999999997
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.00473934	0.47393399999999997
LENNOX-GASTAUT SYNDROME	0.00473934	0.47393399999999997
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.00473934	0.47393399999999997
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00473934	0.47393399999999997
MANGANESE POISONING	0.00473934	0.47393399999999997
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.00473934	0.47393399999999997
LOWE OCULOCEREBRORENAL SYNDROME	0.00473934	0.47393399999999997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.00473934	0.47393399999999997
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.00473934	0.47393399999999997
CHROMOSOME 2Q37 DELETION SYNDROME	0.00473934	0.47393399999999997
VELOCARDIOFACIAL SYNDROME	0.00473934	0.47393399999999997
16P13.11 MICRODUPLICATION SYNDROME	0.00473934	0.47393399999999997
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.00473934	0.47393399999999997
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00473934	0.47393399999999997
MOEBIUS SYNDROME	0.00470578	0.47057799999999994
KNIEST DYSPLASIA	0.00470578	0.47057799999999994
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0046989300000000005	0.46989300000000006
DE BARSY SYNDROME	0.0046989300000000005	0.46989300000000006
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.0046989300000000005	0.46989300000000006
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0046989300000000005	0.46989300000000006
20Q13.33 MICRODELETION SYNDROME	0.0046989300000000005	0.46989300000000006
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0046989300000000005	0.46989300000000006
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0046989300000000005	0.46989300000000006
20P13 MICRODELETION SYNDROME	0.0046989300000000005	0.46989300000000006
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0046989300000000005	0.46989300000000006
WEAVER SYNDROME	0.0046989300000000005	0.46989300000000006
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.0046989300000000005	0.46989300000000006
TETRASOMY 9P	0.0046989300000000005	0.46989300000000006
DISTAL TRISOMY 5Q	0.0046989300000000005	0.46989300000000006
FG SYNDROME TYPE 1	0.0046989300000000005	0.46989300000000006
WRINKLY SKIN SYNDROME	0.0046989300000000005	0.46989300000000006
SHUKLA-VERNON SYNDROME; SHUVER	0.0046989300000000005	0.46989300000000006
TRISOMY 4P	0.0046387600000000005	0.46387600000000007
LEPRECHAUNISM	0.0046387600000000005	0.46387600000000007
DEAFNESS-HYPOGONADISM SYNDROME	0.0046387600000000005	0.46387600000000007
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.0046387600000000005	0.46387600000000007
TRISOMY X	0.0046387600000000005	0.46387600000000007
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.0046387600000000005	0.46387600000000007
DISTAL MONOSOMY 13Q	0.0046387600000000005	0.46387600000000007
TRISOMY 12P	0.00457714	0.45771400000000007
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.00457714	0.45771400000000007
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00457714	0.45771400000000007
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00457714	0.45771400000000007
FRYNS SYNDROME	0.00457714	0.45771400000000007
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.00457714	0.45771400000000007
ZUNICH NEUROECTODERMAL SYNDROME	0.00457714	0.45771400000000007
ACROCARDIOFACIAL SYNDROME	0.00457714	0.45771400000000007
TRISOMY 8Q	0.00457714	0.45771400000000007
STROMME SYNDROME; STROMS	0.00457714	0.45771400000000007
BOHRING-OPITZ SYNDROME	0.00457714	0.45771400000000007
MOWAT-WILSON SYNDROME	0.00457714	0.45771400000000007
FACIOCARDIORENAL SYNDROME	0.00457714	0.45771400000000007
FRYNS SYNDROME; FRNS	0.00457714	0.45771400000000007
DOORS SYNDROME	0.00457714	0.45771400000000007
BASAL CELL NEVUS SYNDROME	0.00457714	0.45771400000000007
FRONTONASAL DYSPLASIA	0.00457714	0.45771400000000007
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.00457714	0.45771400000000007
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.00457714	0.45771400000000007
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.00457714	0.45771400000000007
TARP SYNDROME; TARPS	0.00457714	0.45771400000000007
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.0045187100000000004	0.451871
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0045187100000000004	0.451871
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0045187100000000004	0.451871
PFEIFFER SYNDROME	0.0045187100000000004	0.451871
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0045187100000000004	0.451871
MONOSOMY 13Q14	0.0045187100000000004	0.451871
FRONTONASAL DYSPLASIA 1; FND1	0.0045187100000000004	0.451871
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00451726	0.451726
48,XXXY SYNDROME	0.00451726	0.451726
19P13.12 MICRODELETION SYNDROME	0.00451726	0.451726
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.00451726	0.451726
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00451726	0.451726
LINEAR NEVUS SEBACEUS SYNDROME	0.0045045	0.45044999999999996
SATOYOSHI SYNDROME	0.0045045	0.45044999999999996
HALLERMANN-STREIFF SYNDROME	0.0045045	0.45044999999999996
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.0045045	0.45044999999999996
KNOBLOCH SYNDROME 1; KNO1	0.0045045	0.45044999999999996
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.0045045	0.45044999999999996
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0045045	0.45044999999999996
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.0045045	0.45044999999999996
ODONTO-ONYCHO DYSPLASIA-ALOPECIA SYNDROME	0.0045045	0.45044999999999996
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1; PPKCA1	0.0045045	0.45044999999999996
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0045045	0.45044999999999996
VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR	0.0045045	0.45044999999999996
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.0045045	0.45044999999999996
MOYNAHAN SYNDROME	0.0045045	0.45044999999999996
ADAMS-OLIVER SYNDROME	0.0045045	0.45044999999999996
ALOPECIA, ANDROGENETIC, 1	0.0045045	0.45044999999999996
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0045045	0.45044999999999996
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.0045045	0.45044999999999996
JOHANSON-BLIZZARD SYNDROME	0.0045045	0.45044999999999996
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.0045045	0.45044999999999996
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.0045045	0.45044999999999996
T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY	0.0045045	0.45044999999999996
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.0045045	0.45044999999999996
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.0045045	0.45044999999999996
PSEUDOPROGERIA SYNDROME	0.0045045	0.45044999999999996
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0045045	0.45044999999999996
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.0045045	0.45044999999999996
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0045045	0.45044999999999996
INSULIN-RESISTANCE SYNDROME TYPE B	0.0045045	0.45044999999999996
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.0045045	0.45044999999999996
CHANARIN-DORFMAN SYNDROME	0.0045045	0.45044999999999996
MANDIBULOACRAL DYSPLASIA	0.0045045	0.45044999999999996
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.0045045	0.45044999999999996
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.0045045	0.45044999999999996
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.0045045	0.45044999999999996
OLIVER-MCFARLANE SYNDROME	0.0045045	0.45044999999999996
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.0045045	0.45044999999999996
ALOPECIA, CONGENITAL	0.0045045	0.45044999999999996
COLCHICINE POISONING	0.0045045	0.45044999999999996
ULERYTHEMA OPHRYOGENESIS	0.0045045	0.45044999999999996
THUMB DEFORMITY AND ALOPECIA	0.0045045	0.45044999999999996
WOODHOUSE-SAKATI SYNDROME	0.0045045	0.45044999999999996
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0045045	0.45044999999999996
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.0045045	0.45044999999999996
LICHEN PLANOPILARIS	0.0045045	0.45044999999999996
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.0045045	0.45044999999999996
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0045045	0.45044999999999996
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.0045045	0.45044999999999996
SCHÖPF-SCHULZ-PASSARGE SYNDROME	0.0045045	0.45044999999999996
KIKUCHI-FUJIMOTO DISEASE	0.0045045	0.45044999999999996
GRAHAM LITTLE-PICCARDI-LASSUEUR SYNDROME	0.0045045	0.45044999999999996
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.0045045	0.45044999999999996
HYPOTRICHOSIS 5; HYPT5	0.0045045	0.45044999999999996
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0045045	0.45044999999999996
KERION CELSI	0.0045045	0.45044999999999996
ATYPICAL WERNER SYNDROME	0.0045045	0.45044999999999996
SARCOIDOSIS	0.0045045	0.45044999999999996
ANE SYNDROME	0.0045045	0.45044999999999996
CENTRIFUGAL LIPODYSTROPHY	0.0045045	0.45044999999999996
LETHAL ACANTHOLYTIC EPIDERMOLYSIS BULLOSA	0.0045045	0.45044999999999996
HYPOTRICHOSIS SIMPLEX	0.0045045	0.45044999999999996
TRICHOTILLOMANIA; TTM	0.0045045	0.45044999999999996
KID SYNDROME	0.0045045	0.45044999999999996
PSEUDOPELADE OF BROCQ	0.0045045	0.45044999999999996
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.0045045	0.45044999999999996
CUTANEOUS MASTOCYTOSIS	0.0045045	0.45044999999999996
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.0045045	0.45044999999999996
ALPHA-HEAVY CHAIN DISEASE	0.0045045	0.45044999999999996
ALSTRÖM SYNDROME	0.0045045	0.45044999999999996
BATHING SUIT ICHTHYOSIS	0.0045045	0.45044999999999996
RELAPSING POLYCHONDRITIS	0.0045045	0.45044999999999996
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.0045045	0.45044999999999996
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.0045045	0.45044999999999996
CANCER, ALOPECIA, PIGMENT DYSCRASIA, ONYCHODYSTROPHY, AND KERATODERMA; CAPOK	0.0045045	0.45044999999999996
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.0045045	0.45044999999999996
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.0045045	0.45044999999999996
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.0045045	0.45044999999999996
PORPHYRIA CUTANEA TARDA	0.0045045	0.45044999999999996
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0045045	0.45044999999999996
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.0045045	0.45044999999999996
BJÖRNSTAD SYNDROME	0.0045045	0.45044999999999996
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.0045045	0.45044999999999996
MIXED CONNECTIVE TISSUE DISEASE	0.0045045	0.45044999999999996
ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION	0.0045045	0.45044999999999996
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.0045045	0.45044999999999996
X-LINKED AGAMMAGLOBULINEMIA	0.0045045	0.45044999999999996
MARIE UNNA HEREDITARY HYPOTRICHOSIS	0.0045045	0.45044999999999996
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.0045045	0.45044999999999996
ECTODERMAL DYSPLASIA 6, HAIR/NAIL TYPE; ECTD6	0.0045045	0.45044999999999996
ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7	0.0045045	0.45044999999999996
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.0045045	0.45044999999999996
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.0045045	0.45044999999999996
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.0045045	0.45044999999999996
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.0045045	0.45044999999999996
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.0045045	0.45044999999999996
MARIE UNNA HEREDITARY HYPOTRICHOSIS 1	0.0045045	0.45044999999999996
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0045045	0.45044999999999996
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0045045	0.45044999999999996
HYPOTRICHOSIS 11; HYPT11	0.0045045	0.45044999999999996
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.0045045	0.45044999999999996
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.0045045	0.45044999999999996
CRANDALL SYNDROME	0.0045045	0.45044999999999996
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0045045	0.45044999999999996
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	0.0045045	0.45044999999999996
CHRONIC GRAFT VERSUS HOST DISEASE	0.0045045	0.45044999999999996
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.0045045	0.45044999999999996
HYPOGONADISM, PRIMARY, AND PARTIAL ALOPECIA	0.0045045	0.45044999999999996
WOODHOUSE-SAKATI SYNDROME	0.0045045	0.45044999999999996
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.0045045	0.45044999999999996
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.0045045	0.45044999999999996
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.0045045	0.45044999999999996
MONILETHRIX; MNLIX	0.0045045	0.45044999999999996
HEMOCHROMATOSIS, TYPE 1	0.0045045	0.45044999999999996
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.0045045	0.45044999999999996
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.0045045	0.45044999999999996
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.0045045	0.45044999999999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.004485620000000001	0.44856200000000007
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.004485620000000001	0.44856200000000007
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.004485620000000001	0.44856200000000007
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.004485620000000001	0.44856200000000007
IMMUNODEFICIENCY 49; IMD49	0.004485620000000001	0.44856200000000007
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.004485620000000001	0.44856200000000007
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.004485620000000001	0.44856200000000007
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004485620000000001	0.44856200000000007
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.004485620000000001	0.44856200000000007
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004485620000000001	0.44856200000000007
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004485620000000001	0.44856200000000007
ACRODYSOSTOSIS	0.00447121	0.447121
AXENFELD-RIEGER SYNDROME	0.00447121	0.447121
BARBER-SAY SYNDROME	0.00447121	0.447121
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00447121	0.447121
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00447121	0.447121
VERVERI-BRADY SYNDROME; VERBRAS	0.00445883	0.44588300000000003
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.00445883	0.44588300000000003
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.0044588299999999996	0.445883
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0044588299999999996	0.445883
SHASHI-PENA SYNDROME; SHAPNS	0.0044588299999999996	0.445883
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.00441755	0.441755
ANTLEY-BIXLER SYNDROME	0.00441755	0.441755
THOMAS SYNDROME	0.00441755	0.441755
RAINE SYNDROME	0.00441755	0.441755
RITSCHER-SCHINZEL SYNDROME 1	0.00441755	0.441755
AYMÉ-GRIPP SYNDROME	0.00441755	0.441755
FIBROCHONDROGENESIS	0.00441755	0.441755
2Q24 MICRODELETION SYNDROME	0.00441755	0.441755
CHROMOSOME 15Q25 DELETION SYNDROME	0.00441755	0.441755
CEREBROFACIOTHORACIC DYSPLASIA	0.00441755	0.441755
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00441755	0.441755
TRISOMY 1Q	0.00441755	0.441755
DIAMOND-BLACKFAN ANEMIA 1	0.00441755	0.441755
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.00441133	0.441133
GENITOPATELLAR SYNDROME	0.00441133	0.441133
8P23.1 DUPLICATION SYNDROME	0.00441133	0.441133
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00441133	0.441133
NOONAN SYNDROME 4; NS4	0.00435912	0.435912
NOONAN SYNDROME 11; NS11	0.00435912	0.435912
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.00435912	0.435912
NOONAN SYNDROME	0.00435912	0.435912
CREE MENTAL RETARDATION SYNDROME	0.00435912	0.435912
PROTEUS SYNDROME	0.00435912	0.435912
CUTIS LAXA	0.00435912	0.435912
FRIAS SYNDROME	0.00435912	0.435912
NOONAN SYNDROME 9; NS9	0.00435912	0.435912
LOEYS-DIETZ SYNDROME 5	0.00435912	0.435912
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00435912	0.435912
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.00435912	0.435912
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00435912	0.435912
NOONAN SYNDROME 10; NS10	0.00435912	0.435912
JOUBERT SYNDROME 14	0.00435912	0.435912
NEUROFACIODIGITORENAL SYNDROME	0.00435912	0.435912
NOONAN SYNDROME 5; NS5	0.00435912	0.435912
LATERAL MENINGOCELE SYNDROME	0.00435912	0.435912
MESOMELIA-SYNOSTOSES SYNDROME	0.00435912	0.435912
SHPRINTZEN-GOLDBERG SYNDROME	0.00435912	0.435912
LEGIUS SYNDROME	0.00435912	0.435912
LATERAL MENINGOCELE SYNDROME	0.00435912	0.435912
COSTELLO SYNDROME; CSTLO	0.00435912	0.435912
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00435912	0.435912
NOONAN SYNDROME 2; NS2	0.00435912	0.435912
NOONAN SYNDROME 8; NS8	0.00435912	0.435912
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00431162	0.43116200000000005
POTOCKI-LUPSKI SYNDROME	0.00431162	0.43116200000000005
17P11.2 MICRODUPLICATION SYNDROME	0.00431162	0.43116200000000005
CAT-EYE SYNDROME	0.00431162	0.43116200000000005
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.00431162	0.43116200000000005
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.00431162	0.43116200000000005
XP22.13P22.2 DUPLICATION SYNDROME	0.00431162	0.43116200000000005
SCHINDLER DISEASE, TYPE I	0.00431034	0.43103400000000003
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.00431034	0.43103400000000003
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.00431034	0.43103400000000003
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00431034	0.43103400000000003
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.00431034	0.43103400000000003
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.00431034	0.43103400000000003
CHOREOACANTHOCYTOSIS	0.00431034	0.43103400000000003
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.00431034	0.43103400000000003
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00431034	0.43103400000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.00431034	0.43103400000000003
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.00431034	0.43103400000000003
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.00431034	0.43103400000000003
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.00431034	0.43103400000000003
HUNTINGTON DISEASE	0.00431034	0.43103400000000003
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00431034	0.43103400000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.00431034	0.43103400000000003
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00431034	0.43103400000000003
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.00431034	0.43103400000000003
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.00431034	0.43103400000000003
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.00431034	0.43103400000000003
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00431034	0.43103400000000003
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.00431034	0.43103400000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00431034	0.43103400000000003
AICARDI-GOUTIERES SYNDROME 6	0.00431034	0.43103400000000003
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.00431034	0.43103400000000003
OPTIC PATHWAY GLIOMA	0.00431034	0.43103400000000003
WEST SYNDROME	0.00431034	0.43103400000000003
WHIPPLE DISEASE	0.00431034	0.43103400000000003
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.00431034	0.43103400000000003
WOLFRAM SYNDROME	0.00431034	0.43103400000000003
INFANTILE NEUROAXONAL DYSTROPHY	0.00431034	0.43103400000000003
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.00431034	0.43103400000000003
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.00431034	0.43103400000000003
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.00431034	0.43103400000000003
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00431034	0.43103400000000003
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.00431034	0.43103400000000003
CHÉDIAK-HIGASHI SYNDROME	0.00431034	0.43103400000000003
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00431034	0.43103400000000003
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.00431034	0.43103400000000003
TRIPLE A SYNDROME	0.00431034	0.43103400000000003
ALPERS-HUTTENLOCHER SYNDROME	0.00431034	0.43103400000000003
CARNOSINASE DEFICIENCY	0.00431034	0.43103400000000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.00431034	0.43103400000000003
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.00431034	0.43103400000000003
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.00431034	0.43103400000000003
CADASIL	0.00431034	0.43103400000000003
RETT SYNDROME, CONGENITAL VARIANT	0.00431034	0.43103400000000003
BEHÇET DISEASE	0.00431034	0.43103400000000003
SNEDDON SYNDROME	0.00431034	0.43103400000000003
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.00431034	0.43103400000000003
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.00431034	0.43103400000000003
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00431034	0.43103400000000003
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00431034	0.43103400000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.00431034	0.43103400000000003
DOWN SYNDROME	0.00431034	0.43103400000000003
DILATED CARDIOMYOPATHY WITH ATAXIA	0.00431034	0.43103400000000003
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.00431034	0.43103400000000003
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.00431034	0.43103400000000003
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00431034	0.43103400000000003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.00431034	0.43103400000000003
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.00431034	0.43103400000000003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00431034	0.43103400000000003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00431034	0.43103400000000003
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.43103400000000003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.00431034	0.43103400000000003
COG8-CDG	0.00431034	0.43103400000000003
ATAXIA WITH VITAMIN E DEFICIENCY	0.00431034	0.43103400000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.00431034	0.43103400000000003
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.00431034	0.43103400000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.00431034	0.43103400000000003
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.00431034	0.43103400000000003
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00431034	0.43103400000000003
NEUROFERRITINOPATHY	0.00431034	0.43103400000000003
LYNCH SYNDROME	0.00431034	0.43103400000000003
FAMILIAL COLORECTAL CANCER TYPE X	0.00431034	0.43103400000000003
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00431034	0.43103400000000003
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.00431034	0.43103400000000003
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.00431034	0.43103400000000003
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.00431034	0.43103400000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.00431034	0.43103400000000003
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00431034	0.43103400000000003
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.00431034	0.43103400000000003
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00431034	0.43103400000000003
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00431034	0.43103400000000003
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.00431034	0.43103400000000003
PANDAS	0.00431034	0.43103400000000003
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.00431034	0.43103400000000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.00431034	0.43103400000000003
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00431034	0.43103400000000003
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.00431034	0.43103400000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.00431034	0.43103400000000003
NORRIE DISEASE	0.00431034	0.43103400000000003
MULTIPLE SULFATASE DEFICIENCY	0.00431034	0.43103400000000003
ALEXANDER DISEASE	0.00431034	0.43103400000000003
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00431034	0.43103400000000003
FRONTOFACIONASAL DYSPLASIA	0.00417745	0.41774500000000003
MARDEN-WALKER SYNDROME	0.00417745	0.41774500000000003
3MC SYNDROME 1	0.00417745	0.41774500000000003
FETAL HYDANTOIN SYNDROME	0.00417745	0.41774500000000003
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00417745	0.41774500000000003
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00417745	0.41774500000000003
SCHWARTZ-JAMPEL SYNDROME	0.00417745	0.41774500000000003
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00417745	0.41774500000000003
SAETHRE-CHOTZEN SYNDROME	0.00417745	0.41774500000000003
FRONTORHINY	0.00417745	0.41774500000000003
MOSAIC TRISOMY 8	0.00412995	0.412995
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00412995	0.412995
CAMPOMELIC DYSPLASIA	0.00412995	0.412995
DUPLICATION OF THE PITUITARY GLAND	0.00412995	0.412995
DIASTROPHIC DWARFISM	0.00412995	0.412995
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00412995	0.412995
CLEIDOCRANIAL DYSPLASIA; CCD	0.00412995	0.412995
CLEIDOCRANIAL DYSPLASIA	0.00412995	0.412995
PFEIFFER SYNDROME TYPE 3	0.00412995	0.412995
CAMPOMELIC DYSPLASIA	0.00412995	0.412995
SIFRIM-HITZ-WEISS SYNDROME	0.00407152	0.407152
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00407152	0.407152
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00407152	0.407152
COG5-CDG	0.0038694000000000003	0.38694
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.0038694000000000003	0.38694
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0038694000000000003	0.38694
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.0038694000000000003	0.38694
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0038694000000000003	0.38694
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0038694000000000003	0.38694
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0038694000000000003	0.38694
SHORT SYNDROME	0.0038694000000000003	0.38694
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0038694000000000003	0.38694
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0038694000000000003	0.38694
8P23.1 MICRODELETION SYNDROME	0.00376969	0.376969
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00376969	0.376969
JOUBERT SYNDROME 10	0.00376969	0.376969
POTOCKI-SHAFFER SYNDROME	0.00376969	0.376969
NEONATAL MARFAN SYNDROME	0.00376969	0.376969
FILIPPI SYNDROME	0.00376969	0.376969
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00376969	0.376969
RING CHROMOSOME 7 SYNDROME	0.00376969	0.376969
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00376969	0.376969
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00370981	0.370981
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.00370981	0.370981
3Q27.3 MICRODELETION SYNDROME	0.00370981	0.370981
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.00370981	0.370981
CHROMOSOME 19P13.13 DELETION SYNDROME	0.00370981	0.370981
MEIER-GORLIN SYNDROME 3; MGORS3	0.00370981	0.370981
MAXILLOFACIAL DYSOSTOSIS	0.00370981	0.370981
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.00370981	0.370981
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00370981	0.370981
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.00370981	0.370981
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.00370981	0.370981
CHROMOSOME 17Q12 DELETION SYNDROME	0.00370981	0.370981
SOTOS SYNDROME 2	0.00370981	0.370981
15Q11Q13 MICRODUPLICATION SYNDROME	0.00370981	0.370981
DISTAL MONOSOMY 12Q	0.00370981	0.370981
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.00370981	0.370981
MERRF	0.00364964	0.364964
PYCNODYSOSTOSIS	0.00364964	0.364964
MALARIA	0.00364964	0.364964
ONDINE SYNDROME	0.00364964	0.364964
MEDULLOBLASTOMA	0.00364964	0.364964
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00364964	0.364964
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00364964	0.364964
LYMPHANGIOLEIOMYOMATOSIS	0.00364964	0.364964
CRISPONI SYNDROME	0.00364964	0.364964
MPDU1-CDG	0.00364964	0.364964
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00364964	0.364964
EARLY-ONSET SCHIZOPHRENIA	0.00364964	0.364964
LEIGH SYNDROME	0.00364964	0.364964
SPINOCEREBELLAR ATAXIA TYPE 14	0.00364964	0.364964
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00364964	0.364964
SPINOCEREBELLAR ATAXIA TYPE 21	0.00364964	0.364964
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00364964	0.364964
SYMMETRICAL THALAMIC CALCIFICATIONS	0.00364964	0.364964
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00364964	0.364964
ALPHA-THALASSEMIA	0.00364964	0.364964
SUSAC SYNDROME	0.00364964	0.364964
SPINOCEREBELLAR ATAXIA 1	0.00364964	0.364964
SPINOCEREBELLAR ATAXIA 32; SCA32	0.00364964	0.364964
ATAXIA-TELANGIECTASIA	0.00364964	0.364964
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.00364964	0.364964
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.00364964	0.364964
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00364964	0.364964
SECKEL SYNDROME 4	0.00364964	0.364964
USHER SYNDROME	0.00364964	0.364964
ALG9-CDG	0.00364964	0.364964
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00364964	0.364964
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.00364964	0.364964
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00364964	0.364964
ALG2-CDG	0.00364964	0.364964
ALG12-CDG	0.00364964	0.364964
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00364964	0.364964
FLOATING-HARBOR SYNDROME	0.00364964	0.364964
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00364964	0.364964
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00364964	0.364964
LYSINURIC PROTEIN INTOLERANCE	0.00364964	0.364964
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00364964	0.364964
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.00364964	0.364964
DYSTONIA-APHONIA SYNDROME	0.00364964	0.364964
EPISODIC ATAXIA TYPE 7	0.00364964	0.364964
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00364964	0.364964
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00364964	0.364964
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00364964	0.364964
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.00364964	0.364964
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00364964	0.364964
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.00364964	0.364964
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00364964	0.364964
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.00364964	0.364964
CONGENITAL SHORT BOWEL SYNDROME	0.00364964	0.364964
MONOAMINE OXIDASE A DEFICIENCY	0.00364964	0.364964
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.00364964	0.364964
ISOLATED CLOVERLEAF SKULL SYNDROME	0.00364964	0.364964
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.00364964	0.364964
REACTIVE ARTHRITIS	0.00364964	0.364964
PHAKOMATOSIS PIGMENTOVASCULARIS	0.00364964	0.364964
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.00364964	0.364964
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00364964	0.364964
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00364964	0.364964
PAPILLOMA OF CHOROID PLEXUS	0.00364964	0.364964
SPINOCEREBELLAR ATAXIA TYPE 32	0.00364964	0.364964
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.00364964	0.364964
SPINOCEREBELLAR ATAXIA 5; SCA5	0.00364964	0.364964
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.00364964	0.364964
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.00364964	0.364964
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00364964	0.364964
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.00364964	0.364964
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.00364964	0.364964
VOGT-KOYANAGI-HARADA DISEASE	0.00364964	0.364964
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00364964	0.364964
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.00364964	0.364964
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00364964	0.364964
DISTAL TRISOMY 18Q	0.00364964	0.364964
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.00364964	0.364964
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.00364964	0.364964
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00364964	0.364964
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00364964	0.364964
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.00364964	0.364964
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.00364964	0.364964
GALACTOSEMIA	0.00364964	0.364964
JOUBERT SYNDROME 4	0.00364964	0.364964
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.00364964	0.364964
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00364964	0.364964
ISOLATED ECTOPIA LENTIS	0.00364964	0.364964
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00364964	0.364964
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00364964	0.364964
BENIGN FAMILIAL NEONATAL EPILEPSY	0.00364964	0.364964
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00364964	0.364964
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00364964	0.364964
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00364964	0.364964
ENDOCARDIAL FIBROELASTOSIS	0.00364964	0.364964
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00364964	0.364964
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.00364964	0.364964
PRUNE BELLY SYNDROME	0.00364964	0.364964
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00364964	0.364964
BARDET-BIEDL SYNDROME 12; BBS12	0.00364964	0.364964
BARDET-BIEDL SYNDROME 5; BBS5	0.00364964	0.364964
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.00364964	0.364964
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00364964	0.364964
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00364964	0.364964
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.00364964	0.364964
BARDET-BIEDL SYNDROME 8; BBS8	0.00364964	0.364964
DYSTONIA 28, CHILDHOOD-ONSET	0.00364964	0.364964
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.00364964	0.364964
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.00364964	0.364964
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.00364964	0.364964
JOUBERT SYNDROME 31; JBTS31	0.00364964	0.364964
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00364964	0.364964
IMMUNODEFICIENCY 23; IMD23	0.00364964	0.364964
SCHIZOPHRENIA 19; SCZD19	0.00364964	0.364964
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.00364964	0.364964
SPINOCEREBELLAR ATAXIA 42	0.00364964	0.364964
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.00364964	0.364964
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00364964	0.364964
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00364964	0.364964
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.00364964	0.364964
BARDET-BIEDL SYNDROME 17; BBS17	0.00364964	0.364964
BARDET-BIEDL SYNDROME 10; BBS10	0.00364964	0.364964
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00364964	0.364964
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.00364964	0.364964
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00364964	0.364964
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00364964	0.364964
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.00364964	0.364964
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.00364964	0.364964
BARDET-BIEDL SYNDROME 18; BBS18	0.00364964	0.364964
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00364964	0.364964
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00364964	0.364964
FACIOCARDIORENAL SYNDROME	0.00358802	0.358802
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.00358802	0.358802
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00358802	0.358802
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00358802	0.358802
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00358802	0.358802
ZECHI-CEIDE SYNDROME	0.00358802	0.358802
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00358802	0.358802
PERLMAN SYNDROME	0.00352959	0.352959
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00352959	0.352959
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.00352959	0.352959
WAARDENBURG SYNDROME	0.00352959	0.352959
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00352959	0.352959
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00352959	0.352959
608028 THAI SYMPHALANGISM SYNDROME	0.00352959	0.352959
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00352959	0.352959
JOUBERT SYNDROME 3; JBTS3	0.00352959	0.352959
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00352814	0.352814
17Q12 MICRODUPLICATION SYNDROME	0.00352814	0.352814
DESBUQUOIS DYSPLASIA 2; DBQD2	0.00352814	0.352814
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00352814	0.352814
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.0034965000000000005	0.34965000000000007
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.0034965000000000005	0.34965000000000007
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.0034965000000000005	0.34965000000000007
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.0034965000000000005	0.34965000000000007
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0034965000000000005	0.34965000000000007
SCHAAF-YANG SYNDROME; SHFYNG	0.0034965000000000005	0.34965000000000007
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0034965000000000005	0.34965000000000007
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0034965000000000005	0.34965000000000007
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.0034965000000000005	0.34965000000000007
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.0034965000000000005	0.34965000000000007
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0034965000000000005	0.34965000000000007
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0034965000000000005	0.34965000000000007
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.0034965000000000005	0.34965000000000007
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0034965000000000005	0.34965000000000007
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.0034965000000000005	0.34965000000000007
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.0034965000000000005	0.34965000000000007
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.0034965000000000005	0.34965000000000007
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0034965000000000005	0.34965000000000007
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.0034965000000000005	0.34965000000000007
ADENYLOSUCCINATE LYASE DEFICIENCY	0.0034965000000000005	0.34965000000000007
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.0034965000000000005	0.34965000000000007
JOUBERT SYNDROME 24	0.0034965000000000005	0.34965000000000007
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.0034965000000000005	0.34965000000000007
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.0034965000000000005	0.34965000000000007
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0034965000000000005	0.34965000000000007
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0034965000000000005	0.34965000000000007
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.0034965000000000005	0.34965000000000007
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.0034965000000000005	0.34965000000000007
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0034965000000000005	0.34965000000000007
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.0034965000000000005	0.34965000000000007
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.0034965000000000005	0.34965000000000007
INFANTILE DYSTONIA-PARKINSONISM	0.0034965000000000005	0.34965000000000007
LISSENCEPHALY 8; LIS8	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.0034965000000000005	0.34965000000000007
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.0034965000000000005	0.34965000000000007
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0034965000000000005	0.34965000000000007
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0034965000000000005	0.34965000000000007
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.0034965000000000005	0.34965000000000007
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.0034965000000000005	0.34965000000000007
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0034965000000000005	0.34965000000000007
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.0034965000000000005	0.34965000000000007
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.0034965000000000005	0.34965000000000007
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.0034965000000000005	0.34965000000000007
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, X-LINKED 98; MRX98	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.0034965000000000005	0.34965000000000007
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.0034965000000000005	0.34965000000000007
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0034965000000000005	0.34965000000000007
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0034965000000000005	0.34965000000000007
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0034965000000000005	0.34965000000000007
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.0034965000000000005	0.34965000000000007
OLIVER SYNDROME	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, X-LINKED 101; MRX101	0.0034965000000000005	0.34965000000000007
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0034965000000000005	0.34965000000000007
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, X-LINKED 103	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, X-LINKED 105; MRX105	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0034965000000000005	0.34965000000000007
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.0034965000000000005	0.34965000000000007
COG4-CDG	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0034965000000000005	0.34965000000000007
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0034965000000000005	0.34965000000000007
MUCOLIPIDOSIS IV; ML4	0.0034965000000000005	0.34965000000000007
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.0034965000000000005	0.34965000000000007
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0034965000000000005	0.34965000000000007
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.0034965000000000005	0.34965000000000007
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0034965000000000005	0.34965000000000007
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.0034965000000000005	0.34965000000000007
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.0034965000000000005	0.34965000000000007
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0034965000000000005	0.34965000000000007
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0034965000000000005	0.34965000000000007
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.0034965000000000005	0.34965000000000007
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0034965000000000005	0.34965000000000007
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0034965000000000005	0.34965000000000007
ANGELMAN SYNDROME	0.0034965000000000005	0.34965000000000007
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0034965000000000005	0.34965000000000007
AL-RAQAD SYNDROME; ARS	0.0034965000000000005	0.34965000000000007
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.0034965000000000005	0.34965000000000007
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0034965000000000005	0.34965000000000007
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0034965000000000005	0.34965000000000007
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0034965000000000005	0.34965000000000007
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0034965000000000005	0.34965000000000007
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.0034965000000000005	0.34965000000000007
XQ28 (MECP2) DUPLICATION	0.0034965000000000005	0.34965000000000007
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.0034965000000000005	0.34965000000000007
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0034965000000000005	0.34965000000000007
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0034965000000000005	0.34965000000000007
ANGELMAN SYNDROME	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0034965000000000005	0.34965000000000007
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0034965000000000005	0.34965000000000007
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.0034965000000000005	0.34965000000000007
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.0034965000000000005	0.34965000000000007
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.0034965000000000005	0.34965000000000007
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0034965000000000005	0.34965000000000007
PEHO-LIKE SYNDROME; PEHOL	0.0034965000000000005	0.34965000000000007
MUCOLIPIDOSIS TYPE IV	0.0034965000000000005	0.34965000000000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0034965000000000005	0.34965000000000007
WARBURG MICRO SYNDROME 2; WARBM2	0.0034965000000000005	0.34965000000000007
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.0034965000000000005	0.34965000000000007
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.0034965000000000005	0.34965000000000007
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.0034965000000000005	0.34965000000000007
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00348209	0.348209
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00348209	0.348209
ZIMMERMANN-LABAND SYNDROME 1	0.00348209	0.348209
HURLER SYNDROME	0.00348209	0.348209
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.00348209	0.348209
PIEBALDISM	0.00348209	0.348209
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.00348209	0.348209
FEINGOLD SYNDROME 1; FGLDS1	0.00348209	0.348209
WAARDENBURG-SHAH SYNDROME	0.00348209	0.348209
EMANUEL SYNDROME	0.00346971	0.346971
JOUBERT SYNDROME 30; JBTS30	0.00346971	0.346971
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.00346971	0.346971
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.00346971	0.346971
11Q22.2Q22.3 MICRODELETION SYNDROME	0.00346971	0.346971
WIEACKER-WOLFF SYNDROME	0.00346971	0.346971
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00346971	0.346971
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00346971	0.346971
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.00346971	0.346971
9Q21.13 MICRODELETION SYNDROME	0.00346971	0.346971
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00346971	0.346971
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00346971	0.346971
CHROMOSOME 5Q12 DELETION SYNDROME	0.00346971	0.346971
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.00342843	0.342843
MARFAN SYNDROME	0.00342843	0.342843
SECKEL SYNDROME 1; SCKL1	0.00342843	0.342843
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00342843	0.342843
AGNATHIA-OTOCEPHALY COMPLEX	0.00342843	0.342843
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00342843	0.342843
LOWRY-MACLEAN SYNDROME	0.00342843	0.342843
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.00342843	0.342843
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00342843	0.342843
TREACHER COLLINS SYNDROME 2; TCS2	0.00342843	0.342843
TREACHER COLLINS SYNDROME 3; TCS3	0.00342843	0.342843
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00342843	0.342843
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.00342843	0.342843
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00342843	0.342843
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00342221	0.342221
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00342221	0.342221
SIALIDOSIS TYPE 2	0.00342221	0.342221
16Q24.3 MICRODELETION SYNDROME	0.00342221	0.342221
PELIZAEUS-MERZBACHER DISEASE	0.00342221	0.342221
13Q12.3 MICRODELETION SYNDROME	0.00342221	0.342221
CRIGLER-NAJJAR SYNDROME TYPE 1	0.00342221	0.342221
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00342221	0.342221
OROFACIODIGITAL SYNDROME XVII	0.00342221	0.342221
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00342221	0.342221
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00342221	0.342221
RUVALCABA SYNDROME	0.00337	0.337
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.00337	0.337
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00337	0.337
HYPERTRICHOSIS CUBITI	0.00337	0.337
DISTAL TRISOMY 15Q	0.00337	0.337
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00337	0.337
SCARF SYNDROME	0.00337	0.337
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00337	0.337
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.00337	0.337
PROTEUS SYNDROME	0.00337	0.337
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00337	0.337
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00337	0.337
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.00337	0.337
2P15-16.1 MICRODELETION SYNDROME	0.00337	0.337
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.0033225	0.33225
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.0033225	0.33225
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.0033225	0.33225
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0033225	0.33225
GENITOPATELLAR SYNDROME; GTPTS	0.0033225	0.33225
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.0033225	0.33225
THANATOPHORIC DYSPLASIA	0.0033225	0.33225
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0033225	0.33225
WAARDENBURG SYNDROME TYPE 3	0.0033225	0.33225
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0033225	0.33225
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0033225	0.33225
JOUBERT SYNDROME WITH OCULAR DEFECT	0.00318833	0.31883300000000003
NAIL-PATELLA SYNDROME	0.00318833	0.31883300000000003
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00318833	0.31883300000000003
TYSHCHENKO SYNDROME	0.00318833	0.31883300000000003
JOUBERT SYNDROME WITH RENAL DEFECT	0.00318833	0.31883300000000003
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00318833	0.31883300000000003
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00318833	0.31883300000000003
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00318833	0.31883300000000003
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00318833	0.31883300000000003
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00318833	0.31883300000000003
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.00318833	0.31883300000000003
KABUKI SYNDROME	0.00318833	0.31883300000000003
KALLMANN SYNDROME	0.00318833	0.31883300000000003
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00318833	0.31883300000000003
MECKEL SYNDROME, TYPE 10; MKS10	0.00318833	0.31883300000000003
CDAGS SYNDROME	0.00318833	0.31883300000000003
AASE-SMITH SYNDROME I	0.00318833	0.31883300000000003
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00314083	0.314083
CHARGE-LIKE SYNDROME, X-LINKED	0.00314083	0.314083
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.00314083	0.314083
TIBIAL HEMIMELIA	0.00314083	0.314083
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.00314083	0.314083
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00314083	0.314083
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.00314083	0.314083
HARDIKAR SYNDROME	0.00314083	0.314083
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00314083	0.314083
MEIER-GORLIN SYNDROME 1; MGORS1	0.00314083	0.314083
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00314083	0.314083
DIABETIC EMBRYOPATHY	0.00314083	0.314083
MEIER-GORLIN SYNDROME 7	0.00314083	0.314083
RAPADILINO SYNDROME	0.00314083	0.314083
GORDON SYNDROME	0.00314083	0.314083
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.00314083	0.314083
BOR SYNDROME	0.00314083	0.314083
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0030824	0.30824
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.0030824	0.30824
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0030824	0.30824
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.0030824	0.30824
SPINOCEREBELLAR ATAXIA TYPE 36	0.0030824	0.30824
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.0030824	0.30824
RHYNS SYNDROME	0.0030824	0.30824
MYASTHENIA GRAVIS	0.0030824	0.30824
AURICULOCONDYLAR SYNDROME	0.0030824	0.30824
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.0030824	0.30824
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.0030824	0.30824
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00295376	0.295376
600736 VELOFACIOSKELETAL SYNDROME	0.00295376	0.295376
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00295376	0.295376
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00295376	0.295376
STEEL SYNDROME; STLS	0.00295376	0.295376
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.00295376	0.295376
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00295376	0.295376
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.00295376	0.295376
CHROMOSOME 16Q22 DELETION SYNDROME	0.00295376	0.295376
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00295376	0.295376
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00295376	0.295376
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.00295376	0.295376
HENNEKAM SYNDROME	0.00295376	0.295376
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.00295376	0.295376
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00295376	0.295376
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.00295376	0.295376
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00295376	0.295376
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00295376	0.295376
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.00295376	0.295376
3Q13 MICRODELETION SYNDROME	0.00295376	0.295376
GORLIN SYNDROME	0.00295376	0.295376
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00295376	0.295376
PYRUVATE DEHYDROGENASE DEFICIENCY	0.00295376	0.295376
PENTASOMY X	0.00295376	0.295376
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00295376	0.295376
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.00295376	0.295376
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00295376	0.295376
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00295376	0.295376
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00295376	0.295376
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.00295376	0.295376
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00295376	0.295376
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00295376	0.295376
CHROMOSOME 18P DELETION SYNDROME	0.00295376	0.295376
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00295376	0.295376
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.00295376	0.295376
CHARLIE M SYNDROME	0.00295376	0.295376
INTELLECTUAL DISABILITY, WOLFF TYPE	0.00295376	0.295376
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.00295376	0.295376
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00295376	0.295376
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.00295376	0.295376
RING CHROMOSOME 6 SYNDROME	0.00295376	0.295376
SIALURIA	0.00295376	0.295376
OROFACIODIGITAL SYNDROME XV; OFD15	0.00295376	0.295376
DIAMOND-BLACKFAN ANEMIA 8	0.00295376	0.295376
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00295376	0.295376
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.00295376	0.295376
ROIFMAN-CHITAYAT SYNDROME	0.00295376	0.295376
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00295376	0.295376
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00295376	0.295376
TETRASOMY 5P	0.00295376	0.295376
CRANIOMETAPHYSEAL DYSPLASIA	0.00295376	0.295376
FRASER SYNDROME	0.00295376	0.295376
DIGEORGE SYNDROME; DGS	0.0028938799999999997	0.289388
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.0028938799999999997	0.289388
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0028938799999999997	0.289388
SAY-BARBER-MILLER SYNDROME	0.0028938799999999997	0.289388
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.0028938799999999997	0.289388
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.0028938799999999997	0.289388
CRANIOLENTICULOSUTURAL DYSPLASIA	0.0028938799999999997	0.289388
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0028938799999999997	0.289388
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.0028938799999999997	0.289388
12Q14 MICRODELETION SYNDROME	0.0028938799999999997	0.289388
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0028938799999999997	0.289388
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.0028938799999999997	0.289388
6Q16 MICRODELETION SYNDROME	0.0028938799999999997	0.289388
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0028938799999999997	0.289388
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.0028938799999999997	0.289388
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.0028938799999999997	0.289388
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0028938799999999997	0.289388
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.0028938799999999997	0.289388
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0028938799999999997	0.289388
CHITAYAT SYNDROME	0.0028938799999999997	0.289388
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.0028938799999999997	0.289388
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.0028938799999999997	0.289388
49,XYYYY SYNDROME	0.0028938799999999997	0.289388
47,XYY SYNDROME	0.0028938799999999997	0.289388
1Q44 MICRODELETION SYNDROME	0.0028938799999999997	0.289388
XQ12-Q13.3 DUPLICATION SYNDROME	0.0028938799999999997	0.289388
7P22.1 MICRODUPLICATION SYNDROME	0.0028938799999999997	0.289388
6Q TERMINAL DELETION SYNDROME	0.0028938799999999997	0.289388
PMM2-CDG	0.0028938799999999997	0.289388
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.0027941700000000003	0.279417
ARTERIAL TORTUOSITY SYNDROME	0.0027941700000000003	0.279417
PAI SYNDROME	0.0027941700000000003	0.279417
SOTOS SYNDROME	0.0027941700000000003	0.279417
AUTISM, SUSCEPTIBILITY TO, 18	0.0027941700000000003	0.279417
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0027941700000000003	0.279417
FRONTOMETAPHYSEAL DYSPLASIA	0.0027941700000000003	0.279417
DONNAI-BARROW SYNDROME	0.0027941700000000003	0.279417
SMITH-KINGSMORE SYNDROME; SKS	0.0027941700000000003	0.279417
17P13.3 MICRODUPLICATION SYNDROME	0.0027941700000000003	0.279417
WEAVER SYNDROME	0.0027941700000000003	0.279417
ATKIN-FLAITZ SYNDROME	0.0027941700000000003	0.279417
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0027941700000000003	0.279417
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.0027941700000000003	0.279417
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0027941700000000003	0.279417
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0027941700000000003	0.279417
TEMTAMY SYNDROME; TEMTYS	0.0027941700000000003	0.279417
XIA-GIBBS SYNDROME	0.0027941700000000003	0.279417
ZIMMERMANN-LABAND SYNDROME	0.0027941700000000003	0.279417
MONOSOMY 13Q34	0.0027941700000000003	0.279417
19P13.13 MICRODELETION SYNDROME	0.0027941700000000003	0.279417
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.0027941700000000003	0.279417
NOONAN SYNDROME 3; NS3	0.0027941700000000003	0.279417
JUVENILE POLYPOSIS OF INFANCY	0.0027941700000000003	0.279417
FRANK-TER HAAR SYNDROME; FTHS	0.0027941700000000003	0.279417
RING CHROMOSOME 14 SYNDROME	0.0027941700000000003	0.279417
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.0027941700000000003	0.279417
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.0027941700000000003	0.279417
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.0027941700000000003	0.279417
JUVENILE POLYPOSIS SYNDROME	0.0027941700000000003	0.279417
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.0027941700000000003	0.279417
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0027941700000000003	0.279417
TRISOMY 9P	0.0027941700000000003	0.279417
CHROMOSOME 18Q DELETION SYNDROME	0.0027941700000000003	0.279417
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.0027941700000000003	0.279417
ALAGILLE SYNDROME	0.0027941700000000003	0.279417
MOMO SYNDROME	0.0027941700000000003	0.279417
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.0027941700000000003	0.279417
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0027941700000000003	0.279417
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.0027941700000000003	0.279417
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0027941700000000003	0.279417
10Q22.3Q23.3 MICRODELETION SYNDROME	0.0027941700000000003	0.279417
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.0027941700000000003	0.279417
COFFIN-LOWRY SYNDROME; CLS	0.0027941700000000003	0.279417
COLE-CARPENTER SYNDROME 2; CLCRP2	0.0027941700000000003	0.279417
APERT SYNDROME	0.0027941700000000003	0.279417
W SYNDROME	0.0027941700000000003	0.279417
MEESTER-LOEYS SYNDROME; MRLS	0.0027941700000000003	0.279417
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.0027941700000000003	0.279417
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0027941700000000003	0.279417
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0027941700000000003	0.279417
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.0027941700000000003	0.279417
RESTRICTIVE DERMOPATHY	0.0027941700000000003	0.279417
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.0027941700000000003	0.279417
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0027941700000000003	0.279417
BRANCHIOSKELETOGENITAL SYNDROME	0.0027941700000000003	0.279417
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.0027941700000000003	0.279417
FONTAINE PROGEROID SYNDROME; FPS	0.0027941700000000003	0.279417
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0027941700000000003	0.279417
OROFACIODIGITAL SYNDROME TYPE 6	0.0026125000000000002	0.26125000000000004
KNIEST-LIKE DYSPLASIA, LETHAL	0.0026125000000000002	0.26125000000000004
BALLER-GEROLD SYNDROME	0.0026125000000000002	0.26125000000000004
OROFACIODIGITAL SYNDROME IV; OFD4	0.0026125000000000002	0.26125000000000004
ATELOSTEOGENESIS TYPE I	0.0026125000000000002	0.26125000000000004
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.0026125000000000002	0.26125000000000004
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0026125000000000002	0.26125000000000004
CEREBROOCULONASAL SYNDROME	0.0026125000000000002	0.26125000000000004
NEMALINE MYOPATHY 2; NEM2	0.0026125000000000002	0.26125000000000004
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.0026125000000000002	0.26125000000000004
MECKEL SYNDROME, TYPE 1; MKS1	0.0026125000000000002	0.26125000000000004
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.0026125000000000002	0.26125000000000004
CRANE-HEISE SYNDROME	0.0026125000000000002	0.26125000000000004
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0026125000000000002	0.26125000000000004
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0026125000000000002	0.26125000000000004
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.0026125000000000002	0.26125000000000004
VICI SYNDROME; VICIS	0.0026125000000000002	0.26125000000000004
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.0026125000000000002	0.26125000000000004
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.0026125000000000002	0.26125000000000004
DIAPHANOSPONDYLODYSOSTOSIS	0.0026125000000000002	0.26125000000000004
LOEYS-DIETZ SYNDROME 3; LDS3	0.0026125000000000002	0.26125000000000004
48,XXYY SYNDROME	0.0026125000000000002	0.26125000000000004
LARSEN SYNDROME	0.0026125000000000002	0.26125000000000004
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0026125000000000002	0.26125000000000004
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.0026125000000000002	0.26125000000000004
LARSEN-LIKE SYNDROME	0.0026125000000000002	0.26125000000000004
DISTAL TRISOMY 17Q	0.0026125000000000002	0.26125000000000004
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.0026125000000000002	0.26125000000000004
OCULODENTODIGITAL DYSPLASIA	0.0026125000000000002	0.26125000000000004
TRIPLOIDY	0.0026125000000000002	0.26125000000000004
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.0026125000000000002	0.26125000000000004
MELNICK-NEEDLES SYNDROME	0.0026125000000000002	0.26125000000000004
ACALVARIA	0.0026125000000000002	0.26125000000000004
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.0026125000000000002	0.26125000000000004
49,XXXXY SYNDROME	0.0026125000000000002	0.26125000000000004
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.0026125000000000002	0.26125000000000004
CATEL-MANZKE SYNDROME	0.0026125000000000002	0.26125000000000004
OROFACIODIGITAL SYNDROME VIII; OFD8	0.0026125000000000002	0.26125000000000004
HARTSFIELD SYNDROME; HRTFDS	0.0026125000000000002	0.26125000000000004
ROBERTS SYNDROME	0.0026125000000000002	0.26125000000000004
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.0026125000000000002	0.26125000000000004
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.0026125000000000002	0.26125000000000004
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.0026125000000000002	0.26125000000000004
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0026125000000000002	0.26125000000000004
OROFACIODIGITAL SYNDROME VI	0.0026125000000000002	0.26125000000000004
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.0026125000000000002	0.26125000000000004
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0026125000000000002	0.26125000000000004
SHORT RIB-POLYDACTYLY SYNDROME	0.0026125000000000002	0.26125000000000004
KBG SYNDROME	0.0026125000000000002	0.26125000000000004
MECKEL SYNDROME	0.0026125000000000002	0.26125000000000004
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0026125000000000002	0.26125000000000004
BARTSOCAS-PAPAS SYNDROME; BPS	0.0026125000000000002	0.26125000000000004
TRIOPIA	0.0026125000000000002	0.26125000000000004
PFEIFFER SYNDROME TYPE 2	0.0026125000000000002	0.26125000000000004
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.0026125000000000002	0.26125000000000004
NEU-LAXOVA SYNDROME 2; NLS2	0.0026125000000000002	0.26125000000000004
PETERS PLUS SYNDROME	0.0026125000000000002	0.26125000000000004
FETAL AKINESIA DEFORMATION SEQUENCE	0.0026125000000000002	0.26125000000000004
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.0026125000000000002	0.26125000000000004
MOSAIC TRISOMY 9	0.0026125000000000002	0.26125000000000004
STICKLER SYNDROME	0.0026125000000000002	0.26125000000000004
RENAL AGENESIS, BILATERAL	0.0026125000000000002	0.26125000000000004
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.0025540700000000003	0.25540700000000005
ACRO-RENAL-OCULAR SYNDROME	0.0025540700000000003	0.25540700000000005
ASCHER SYNDROME	0.0025540700000000003	0.25540700000000005
CRANIOSYNOSTOSIS 6; CRS6	0.0025540700000000003	0.25540700000000005
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.0025540700000000003	0.25540700000000005
COACH SYNDROME	0.0025540700000000003	0.25540700000000005
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.0025540700000000003	0.25540700000000005
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.0025540700000000003	0.25540700000000005
SIX2-RELATED FRONTONASAL DYSPLASIA	0.0025540700000000003	0.25540700000000005
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.0025540700000000003	0.25540700000000005
ACROMELIC FRONTONASAL DYSPLASIA	0.0025540700000000003	0.25540700000000005
MCDONOUGH SYNDROME	0.0025540700000000003	0.25540700000000005
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.0025540700000000003	0.25540700000000005
TETRASOMY 12P	0.0025540700000000003	0.25540700000000005
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.0025540700000000003	0.25540700000000005
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.0025540700000000003	0.25540700000000005
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.0025540700000000003	0.25540700000000005
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.0025540700000000003	0.25540700000000005
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.0025540700000000003	0.25540700000000005
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0025540700000000003	0.25540700000000005
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.0025540700000000003	0.25540700000000005
JACKSON-WEISS SYNDROME	0.0025540700000000003	0.25540700000000005
JACOBSEN SYNDROME	0.0025540700000000003	0.25540700000000005
CHAR SYNDROME	0.0025540700000000003	0.25540700000000005
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.0025540700000000003	0.25540700000000005
JUBERG-HAYWARD SYNDROME	0.0025540700000000003	0.25540700000000005
CROUZON DISEASE	0.0025540700000000003	0.25540700000000005
MCDONOUGH SYNDROME	0.0025540700000000003	0.25540700000000005
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0025540700000000003	0.25540700000000005
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.00250657	0.250657
ISOLATED BRACHYCEPHALY	0.00250657	0.250657
NON-DISTAL MONOSOMY 20Q	0.00250657	0.250657
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00250657	0.250657
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00250657	0.250657
MELNICK-NEEDLES SYNDROME	0.00250657	0.250657
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00250657	0.250657
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.00250657	0.250657
PELVISCAPULAR DYSPLASIA	0.00250657	0.250657
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00250657	0.250657
20Q11.2 MICRODELETION SYNDROME	0.00250657	0.250657
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00250657	0.250657
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00250657	0.250657
YUNIS-VARON SYNDROME	0.00250657	0.250657
ALPHA-MANNOSIDOSIS	0.00250657	0.250657
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.00250657	0.250657
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.00250657	0.250657
YUNIS-VARON SYNDROME	0.00250657	0.250657
PFEIFFER SYNDROME TYPE 1	0.00250657	0.250657
CHOPS SYNDROME; CHOPS	0.00250657	0.250657
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00250657	0.250657
SCLEROSTEOSIS 2; SOST2	0.00250657	0.250657
1Q21.1 MICRODELETION SYNDROME	0.00196464	0.19646400000000003
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00196464	0.19646400000000003
ISOLATED TRIGONOCEPHALY	0.00196464	0.19646400000000003
MICRO SYNDROME	0.00196464	0.19646400000000003
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00196464	0.19646400000000003
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00196464	0.19646400000000003
MICROPHTHALMIA, SYNDROMIC 12	0.00196464	0.19646400000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.00196464	0.19646400000000003
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00196464	0.19646400000000003
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.00196464	0.19646400000000003
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00196464	0.19646400000000003
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00196464	0.19646400000000003
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00196464	0.19646400000000003
SHELDON-HALL SYNDROME	0.00196464	0.19646400000000003
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.00196464	0.19646400000000003
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.00196464	0.19646400000000003
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.00196464	0.19646400000000003
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00196464	0.19646400000000003
FILIPPI SYNDROME; FLPIS	0.00196464	0.19646400000000003
8Q12 MICRODUPLICATION SYNDROME	0.00196464	0.19646400000000003
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.00196464	0.19646400000000003
LIG4 SYNDROME	0.00196464	0.19646400000000003
CARPENTER-WAZIRI SYNDROME	0.00196464	0.19646400000000003
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.19646400000000003
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00196464	0.19646400000000003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.19646400000000003
OMODYSPLASIA 1; OMOD1	0.00196464	0.19646400000000003
SIMOSA CRANIOFACIAL SYNDROME	0.00196464	0.19646400000000003
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.00196464	0.19646400000000003
TRISOMY 18-LIKE SYNDROME	0.00196464	0.19646400000000003
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00196464	0.19646400000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.00196464	0.19646400000000003
BEEMER-ERTBRUGGEN SYNDROME	0.00196464	0.19646400000000003
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00196464	0.19646400000000003
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00196464	0.19646400000000003
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00196464	0.19646400000000003
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00196464	0.19646400000000003
MECKEL SYNDROME 12; MKS12	0.00196464	0.19646400000000003
RETINITIS PIGMENTOSA	0.00196464	0.19646400000000003
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00196464	0.19646400000000003
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00196464	0.19646400000000003
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00196464	0.19646400000000003
GLUTAMINE DEFICIENCY, CONGENITAL	0.00196464	0.19646400000000003
MULTIPLE METAPHYSEAL DYSPLASIA	0.00196464	0.19646400000000003
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00196464	0.19646400000000003
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00196464	0.19646400000000003
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00196464	0.19646400000000003
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.00196464	0.19646400000000003
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.19646400000000003
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00196464	0.19646400000000003
CRANIOECTODERMAL DYSPLASIA 1	0.00196464	0.19646400000000003
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00196464	0.19646400000000003
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00196464	0.19646400000000003
FAMILIAL BENIGN COPPER DEFICIENCY	0.00196464	0.19646400000000003
8Q24.3 MICRODELETION SYNDROME	0.00196464	0.19646400000000003
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.00196464	0.19646400000000003
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00196464	0.19646400000000003
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00196464	0.19646400000000003
CRANIODIAPHYSEAL DYSPLASIA	0.00196464	0.19646400000000003
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.19646400000000003
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.00196464	0.19646400000000003
TRISOMY 18P	0.00196464	0.19646400000000003
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00196464	0.19646400000000003
C SYNDROME	0.00196464	0.19646400000000003
BEEMER LETHAL MALFORMATION SYNDROME	0.00196464	0.19646400000000003
BOOMERANG DYSPLASIA	0.00196464	0.19646400000000003
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00196464	0.19646400000000003
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00196464	0.19646400000000003
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00196464	0.19646400000000003
ALAZAMI SYNDROME; ALAZS	0.00196464	0.19646400000000003
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00196464	0.19646400000000003
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00196464	0.19646400000000003
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.00196464	0.19646400000000003
LISSENCEPHALY, X-LINKED, 2	0.00196464	0.19646400000000003
MEGALENCEPHALY	0.00196464	0.19646400000000003
COFS SYNDROME	0.00196464	0.19646400000000003
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00196464	0.19646400000000003
OROFACIODIGITAL SYNDROME TYPE 2	0.00196464	0.19646400000000003
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.00196464	0.19646400000000003
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.00196464	0.19646400000000003
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00196464	0.19646400000000003
MULIBREY NANISM	0.00196464	0.19646400000000003
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00196464	0.19646400000000003
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00196464	0.19646400000000003
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00196464	0.19646400000000003
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00196464	0.19646400000000003
MIETENS SYNDROME	0.00196464	0.19646400000000003
LÉRI-WEILL DYSCHONDROSTEOSIS	0.00196464	0.19646400000000003
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.19646400000000003
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00196464	0.19646400000000003
MATERNAL PHENYLKETONURIA	0.00196464	0.19646400000000003
OCULOECTODERMAL SYNDROME; OES	0.00196464	0.19646400000000003
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00196464	0.19646400000000003
HENNEKAM-BEEMER SYNDROME	0.00196464	0.19646400000000003
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00196464	0.19646400000000003
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.00196464	0.19646400000000003
MENTAL RETARDATION, X-LINKED 95	0.00190476	0.19047599999999998
MENTAL RETARDATION, X-LINKED 93	0.00190476	0.19047599999999998
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00190476	0.19047599999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00190476	0.19047599999999998
17Q11.2 MICRODUPLICATION SYNDROME	0.00190476	0.19047599999999998
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00190476	0.19047599999999998
MENTAL RETARDATION, X-LINKED 19	0.00190476	0.19047599999999998
MENTAL RETARDATION, X-LINKED 90	0.00190476	0.19047599999999998
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00190476	0.19047599999999998
BARATELA-SCOTT SYNDROME	0.00190476	0.19047599999999998
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00190476	0.19047599999999998
MACHADO-JOSEPH DISEASE TYPE 2	0.00190476	0.19047599999999998
MACHADO-JOSEPH DISEASE TYPE 1	0.00190476	0.19047599999999998
SAUL-WILSON SYNDROME; SWILS	0.00190476	0.19047599999999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00190476	0.19047599999999998
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00190476	0.19047599999999998
MENTAL RETARDATION, X-LINKED 9	0.00190476	0.19047599999999998
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00190476	0.19047599999999998
MICROTIA	0.00190476	0.19047599999999998
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.00190476	0.19047599999999998
UNILATERAL POLYMICROGYRIA	0.00190476	0.19047599999999998
BILATERAL POLYMICROGYRIA	0.00190476	0.19047599999999998
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00190476	0.19047599999999998
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.00190476	0.19047599999999998
TEMPLE SYNDROME	0.00190476	0.19047599999999998
MACHADO-JOSEPH DISEASE TYPE 3	0.00190476	0.19047599999999998
POSTORGASMIC ILLNESS SYNDROME	0.00190476	0.19047599999999998
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.00190476	0.19047599999999998
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00190476	0.19047599999999998
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00190476	0.19047599999999998
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.00190476	0.19047599999999998
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.00190476	0.19047599999999998
XQ25 DUPLICATION SYNDROME	0.00190476	0.19047599999999998
HYPOGLOSSIA WITH SITUS INVERSUS	0.00190476	0.19047599999999998
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.00190476	0.19047599999999998
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.00190476	0.19047599999999998
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00190476	0.19047599999999998
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00190476	0.19047599999999998
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.00190476	0.19047599999999998
PARTINGTON SYNDROME	0.00190476	0.19047599999999998
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.00190476	0.19047599999999998
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00190476	0.19047599999999998
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.00190476	0.19047599999999998
LARYNGOTRACHEAL ANGIOMA	0.00190476	0.19047599999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00190476	0.19047599999999998
TENORIO SYNDROME; TNORS	0.00190476	0.19047599999999998
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.00190476	0.19047599999999998
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.00190476	0.19047599999999998
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.00190476	0.19047599999999998
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.19047599999999998
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00190476	0.19047599999999998
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00190476	0.19047599999999998
GALACTOSE EPIMERASE DEFICIENCY	0.00190476	0.19047599999999998
GERODERMA OSTEODYSPLASTICUM; GO	0.00190476	0.19047599999999998
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.19047599999999998
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.00190476	0.19047599999999998
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.00190476	0.19047599999999998
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00190476	0.19047599999999998
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.00190476	0.19047599999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00190476	0.19047599999999998
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00190476	0.19047599999999998
FORSYTHE-WAKELING SYNDROME; FWS	0.00190476	0.19047599999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.00190476	0.19047599999999998
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00190476	0.19047599999999998
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.00190476	0.19047599999999998
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.00190476	0.19047599999999998
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	0.19047599999999998
LANDAU-KLEFFNER SYNDROME	0.00190476	0.19047599999999998
224550 DYSTONIA WITH RINGBINDEN	0.00190476	0.19047599999999998
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00190476	0.19047599999999998
ACERULOPLASMINEMIA	0.00190476	0.19047599999999998
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.00190476	0.19047599999999998
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00190476	0.19047599999999998
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.00190476	0.19047599999999998
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.00190476	0.19047599999999998
AUTISM	0.00190476	0.19047599999999998
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.00190476	0.19047599999999998
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00190476	0.19047599999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.00190476	0.19047599999999998
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00190476	0.19047599999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00190476	0.19047599999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00190476	0.19047599999999998
9Q33.3Q34.11 MICRODELETION SYNDROME	0.00190476	0.19047599999999998
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.00190476	0.19047599999999998
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00190476	0.19047599999999998
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.00190476	0.19047599999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00190476	0.19047599999999998
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00190476	0.19047599999999998
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00190476	0.19047599999999998
CHROMOSOME 13Q14 DELETION SYNDROME	0.00190476	0.19047599999999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.00190476	0.19047599999999998
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00190476	0.19047599999999998
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.00190476	0.19047599999999998
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.00190476	0.19047599999999998
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.00190476	0.19047599999999998
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	0.19047599999999998
RETINITIS PIGMENTOSA 71; RP71	0.00190476	0.19047599999999998
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.00190476	0.19047599999999998
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.00190476	0.19047599999999998
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.00190476	0.19047599999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.00190476	0.19047599999999998
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00190476	0.19047599999999998
PRADER-WILLI SYNDROME; PWS	0.00190476	0.19047599999999998
MILD CANAVAN DISEASE	0.00190476	0.19047599999999998
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00190476	0.19047599999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.00190476	0.19047599999999998
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.00190476	0.19047599999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00190476	0.19047599999999998
FG SYNDROME 2; FGS2	0.00190476	0.19047599999999998
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00190476	0.19047599999999998
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.00190476	0.19047599999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00190476	0.19047599999999998
COFFIN-SIRIS SYNDROME 2; CSS2	0.00190476	0.19047599999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00190476	0.19047599999999998
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.00190476	0.19047599999999998
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.00190476	0.19047599999999998
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00190476	0.19047599999999998
EPILEPSY, PYRIDOXINE-DEPENDENT	0.00190476	0.19047599999999998
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.00190476	0.19047599999999998
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00190476	0.19047599999999998
PROGRESSIVE SUPRANUCLEAR PALSY	0.00190476	0.19047599999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.00190476	0.19047599999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.00190476	0.19047599999999998
KLEEFSTRA SYNDROME 2; KLEFS2	0.00190476	0.19047599999999998
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00190476	0.19047599999999998
EPISODIC ATAXIA TYPE 1	0.00190476	0.19047599999999998
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00190476	0.19047599999999998
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00190476	0.19047599999999998
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00190476	0.19047599999999998
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.19047599999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00190476	0.19047599999999998
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00190476	0.19047599999999998
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00190476	0.19047599999999998
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00190476	0.19047599999999998
EPIDERMAL NEVUS SYNDROME	0.00190476	0.19047599999999998
BRACHYDACTYLY, TYPE A1, D	0.00190476	0.19047599999999998
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.00190476	0.19047599999999998
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00190476	0.19047599999999998
PRADER-WILLI SYNDROME	0.00190476	0.19047599999999998
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00190476	0.19047599999999998
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00190476	0.19047599999999998
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00190476	0.19047599999999998
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.00190476	0.19047599999999998
TEMPLE SYNDROME	0.00190476	0.19047599999999998
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00190476	0.19047599999999998
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.00190476	0.19047599999999998
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00190476	0.19047599999999998
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.00190476	0.19047599999999998
LIG4 SYNDROME	0.00190476	0.19047599999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00190476	0.19047599999999998
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.00190476	0.19047599999999998
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00190476	0.19047599999999998
CRANIOSYNOSTOSIS 7	0.00190476	0.19047599999999998
HAREL-YOON SYNDROME; HAYOS	0.00190476	0.19047599999999998
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.00190476	0.19047599999999998
HUNTINGTON DISEASE-LIKE 1	0.00190476	0.19047599999999998
2Q23.1 MICRODELETION SYNDROME	0.00190476	0.19047599999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.00190476	0.19047599999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.00190476	0.19047599999999998
5Q14.3 MICRODELETION SYNDROME	0.00190476	0.19047599999999998
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00190476	0.19047599999999998
7Q11.23 DUPLICATION SYNDROME	0.00190476	0.19047599999999998
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00190476	0.19047599999999998
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00190476	0.19047599999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.00190476	0.19047599999999998
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00190476	0.19047599999999998
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.00190476	0.19047599999999998
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.00190476	0.19047599999999998
PRIMARY CILIARY DYSKINESIA	0.00190476	0.19047599999999998
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00190476	0.19047599999999998
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00190476	0.19047599999999998
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00190476	0.19047599999999998
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.00190476	0.19047599999999998
MASA SYNDROME	0.00190476	0.19047599999999998
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.00190476	0.19047599999999998
FAMILIAL MULTIPLE LIPOMATOSIS	0.00190476	0.19047599999999998
BARDET-BIEDL SYNDROME 21; BBS21	0.00190476	0.19047599999999998
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.00190476	0.19047599999999998
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00190476	0.19047599999999998
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00190476	0.19047599999999998
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00190476	0.19047599999999998
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00190476	0.19047599999999998
SALLA DISEASE	0.00190476	0.19047599999999998
SPINOCEREBELLAR ATAXIA TYPE 3	0.00190476	0.19047599999999998
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.00190476	0.19047599999999998
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00190476	0.19047599999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.00190476	0.19047599999999998
TETRASOMY 18P	0.00180505	0.180505
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00180505	0.180505
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00180505	0.180505
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00180505	0.180505
OCCIPITAL HORN SYNDROME	0.00180505	0.180505
MONOSOMY 9Q22.3	0.00180505	0.180505
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00180505	0.180505
MONOSOMY 18Q	0.00180505	0.180505
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00180505	0.180505
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.00180505	0.180505
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00180505	0.180505
MARTSOLF SYNDROME	0.00180505	0.180505
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.00180505	0.180505
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.00180505	0.180505
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.180505
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00180505	0.180505
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00180505	0.180505
CLARK-BARAITSER SYNDROME	0.00180505	0.180505
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00180505	0.180505
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.00180505	0.180505
MEVALONIC ACIDURIA	0.00180505	0.180505
MALAN OVERGROWTH SYNDROME	0.00180505	0.180505
CHROMOSOME 16P13.3 DELETION SYNDROME	0.00180505	0.180505
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00180505	0.180505
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.00180505	0.180505
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00180505	0.180505
CONGENITAL HYDROCEPHALUS	0.00180505	0.180505
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00180505	0.180505
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00180505	0.180505
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.180505
ROIFMAN SYNDROME; RFMN	0.00180505	0.180505
MARFAN SYNDROME; MFS	0.00180505	0.180505
PHAVER SYNDROME	0.00180505	0.180505
GMS SYNDROME	0.00180505	0.180505
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.00180505	0.180505
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00180505	0.180505
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00180505	0.180505
CHROMOSOME 17P13.1 DELETION SYNDROME	0.00180505	0.180505
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00180505	0.180505
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00180505	0.180505
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00180505	0.180505
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00180505	0.180505
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00180505	0.180505
CAT-EYE SYNDROME (TYPE I)	0.00180505	0.180505
MEVALONIC ACIDURIA; MEVA	0.00180505	0.180505
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00180505	0.180505
SECKEL SYNDROME 5; SCKL5	0.00180505	0.180505
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00180505	0.180505
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00180505	0.180505
COLE-CARPENTER SYNDROME	0.00180505	0.180505
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00180505	0.180505
DESMOSTEROLOSIS	0.00180505	0.180505
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00180505	0.180505
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.00180505	0.180505
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.180505
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00180505	0.180505
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.00180505	0.180505
ACROOTOOCULAR SYNDROME	0.00180505	0.180505
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.00180505	0.180505
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.00180505	0.180505
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00180505	0.180505
COHEN SYNDROME	0.00180505	0.180505
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00180505	0.180505
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00180505	0.180505
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00180505	0.180505
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00180505	0.180505
VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	0.00180505	0.180505
GABA-TRANSAMINASE DEFICIENCY	0.00180505	0.180505
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00180505	0.180505
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00180505	0.180505
NATIVE AMERICAN MYOPATHY	0.00180505	0.180505
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00180505	0.180505
RUVALCABA SYNDROME	0.00180505	0.180505
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00180505	0.180505
611961 STEVENSON-CAREY SYNDROME	0.00180505	0.180505
PROTEUS-LIKE SYNDROME	0.00180505	0.180505
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00180505	0.180505
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.180505
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.00180505	0.180505
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00180505	0.180505
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00180505	0.180505
OGDEN SYNDROME	0.00180505	0.180505
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.180505
ACRO-RENAL-MANDIBULAR SYNDROME	0.00180505	0.180505
ACRORENAL-MANDIBULAR SYNDROME	0.00180505	0.180505
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00162338	0.162338
SCHISIS ASSOCIATION	0.00162338	0.162338
DIAPHANOSPONDYLODYSOSTOSIS	0.00162338	0.162338
ADDUCTED THUMBS SYNDROME	0.00162338	0.162338
HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	0.00162338	0.162338
PIERRE ROBIN SYNDROME AND OLIGODACTYLY	0.00162338	0.162338
SPRENGEL DEFORMITY	0.00162338	0.162338
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.00162338	0.162338
ANKYLOBLEPHARON FILIFORME ADNATUM-CLEFT PALATE SYNDROME	0.00162338	0.162338
XYLT1-CDG	0.00162338	0.162338
STICKLER SYNDROME TYPE 2	0.00162338	0.162338
STICKLER SYNDROME TYPE 1	0.00162338	0.162338
ISOLATED DANDY-WALKER MALFORMATION	0.00162338	0.162338
C SYNDROME	0.00162338	0.162338
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00162338	0.162338
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00162338	0.162338
STICKLER SYNDROME, TYPE I	0.00162338	0.162338
RETINOBLASTOMA	0.00162338	0.162338
CONGENITAL LARYNGOMALACIA	0.00162338	0.162338
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.00162338	0.162338
ANKYLOBLEPHARON FILIFORME ADNATUM-IMPERFORATE ANUS SYNDROME	0.00162338	0.162338
LETHAL KNIEST-LIKE DYSPLASIA	0.00162338	0.162338
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00162338	0.162338
PRIMARY PULMONARY HYPOPLASIA	0.00162338	0.162338
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.00162338	0.162338
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00162338	0.162338
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.00162338	0.162338
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00162338	0.162338
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00162338	0.162338
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00162338	0.162338
ISOLATED PIERRE ROBIN SYNDROME	0.00162338	0.162338
PIERRE ROBIN SYNDROME	0.00162338	0.162338
260150 PALANT CLEFT PALATE SYNDROME	0.00162338	0.162338
AASE-SMITH SYNDROME	0.00162338	0.162338
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.00162338	0.162338
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00162338	0.162338
BARTSOCAS-PAPAS SYNDROME	0.00162338	0.162338
ATELOSTEOGENESIS, TYPE II	0.00162338	0.162338
WEAVER-WILLIAMS SYNDROME	0.00162338	0.162338
BAMFORTH-LAZARUS SYNDROME	0.00162338	0.162338
SAY SYNDROME	0.00162338	0.162338
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.00162338	0.162338
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.00162338	0.162338
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.00162338	0.162338
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00162338	0.162338
ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE	0.00162338	0.162338
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00162338	0.162338
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00162338	0.162338
MECKEL SYNDROME, TYPE 5	0.00162338	0.162338
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.00162338	0.162338
MEGAEPIPHYSEAL DWARFISM	0.00162338	0.162338
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.00162338	0.162338
TROCHLEA OF THE HUMERUS, APLASIA OF	0.00162338	0.162338
MESOMELIC LIMB SHORTENING AND BOWING	0.00162338	0.162338
OCULOPALATOCEREBRAL SYNDROME	0.00162338	0.162338
OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6	0.00162338	0.162338
RETINOBLASTOMA; RB1	0.00162338	0.162338
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00162338	0.162338
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00162338	0.162338
SCHNECKENBECKEN DYSPLASIA	0.00162338	0.162338
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00162338	0.162338
NIJMEGEN BREAKAGE SYNDROME	0.00162338	0.162338
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.00162338	0.162338
DIAMOND-BLACKFAN ANEMIA 10	0.00162338	0.162338
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00162338	0.162338
KAPUR-TORIELLO SYNDROME	0.00162338	0.162338
DIPROSOPUS	0.00162338	0.162338
OROFACIODIGITAL SYNDROME TYPE 14	0.00162338	0.162338
NIJMEGEN BREAKAGE SYNDROME	0.00162338	0.162338
TETRAPLOIDY	0.00162338	0.162338
MAXILLONASAL DYSPLASIA	0.00162338	0.162338
ABRUZZO-ERICKSON SYNDROME	0.00162338	0.162338
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.00162338	0.162338
STICKLER SYNDROME, TYPE III	0.00162338	0.162338
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00162338	0.162338
BLACKFAN-DIAMOND ANEMIA	0.00162338	0.162338
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00162338	0.162338
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.00162338	0.162338
RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE	0.00162338	0.162338
CAMPOMELIA, CUMMING TYPE	0.00162338	0.162338
ISOTRETINOIN-LIKE SYNDROME	0.00162338	0.162338
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00162338	0.162338
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00162338	0.162338
SCHNECKENBECKEN DYSPLASIA	0.00162338	0.162338
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.00162338	0.162338
PARIETAL FORAMINA	0.00162338	0.162338
KYPHOMELIC DYSPLASIA	0.00162338	0.162338
MECKEL SYNDROME, TYPE 4; MKS4	0.00162338	0.162338
FOCAL DERMAL HYPOPLASIA; FDH	0.00162338	0.162338
AICARDI SYNDROME; AIC	0.00162338	0.162338
AICARDI SYNDROME	0.00162338	0.162338
CATEL-MANZKE SYNDROME; CATMANS	0.00162338	0.162338
MICROFORM HOLOPROSENCEPHALY	0.00162338	0.162338
MICROPHTHALMIA, SYNDROMIC 4	0.00162338	0.162338
SPONDYLOEPIPHYSEAL DYSPLASIA AND SPONDYLOEPIMETAPHYSEAL DYSPLASIA	0.00162338	0.162338
MECKEL SYNDROME, TYPE 6; MKS6	0.00162338	0.162338
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.00162338	0.162338
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00162338	0.162338
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.00162338	0.162338
PELVIS-SHOULDER DYSPLASIA	0.00162338	0.162338
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00162338	0.162338
2Q33.1 DELETION SYNDROME	0.00162338	0.162338
ROSSELLI-GULIENETTI SYNDROME	0.00162338	0.162338
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00162338	0.162338
OTOMANDIBULAR SYNDROME	0.00162338	0.162338
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00162338	0.162338
PHOCOMELIA, SCHINZEL TYPE	0.00162338	0.162338
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00162338	0.162338
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.00162338	0.162338
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.00162338	0.162338
OCULODENTODIGITAL DYSPLASIA; ODDD	0.00162338	0.162338
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.00162338	0.162338
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00162338	0.162338
HEMIFACIAL MICROSOMIA	0.00162338	0.162338
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.00162338	0.162338
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00162338	0.162338
LOWRY-MACLEAN SYNDROME	0.00162338	0.162338
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00162338	0.162338
CULLER-JONES SYNDROME; CJS	0.00162338	0.162338
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00162338	0.162338
BRANCHIOOTIC SYNDROME	0.00162338	0.162338
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00162338	0.162338
THORACOABDOMINAL SYNDROME	0.00162338	0.162338
CLEFT PALATE-STAPES FIXATION-OLIGODONTIA SYNDROME	0.00162338	0.162338
CLEFT PALATE	0.00162338	0.162338
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.00162338	0.162338
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.00162338	0.162338
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00162338	0.162338
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.00162338	0.162338
METATROPIC DYSPLASIA	0.00162338	0.162338
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.00162338	0.162338
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.00162338	0.162338
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00162338	0.162338
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00162338	0.162338
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.00162338	0.162338
ACROPECTOROVERTEBRAL DYSPLASIA	0.00162338	0.162338
BRANCHIOGENIC DEAFNESS SYNDROME	0.00162338	0.162338
FAMILIAL VISCERAL MYOPATHY	0.00162338	0.162338
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00162338	0.162338
OCULO-PALATO-CEREBRAL SYNDROME	0.00162338	0.162338
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.00162338	0.162338
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.00162338	0.162338
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.00162338	0.162338
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.00162338	0.162338
LYMPHEDEMA, HEREDITARY, II	0.00162338	0.162338
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.00162338	0.162338
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00162338	0.162338
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00162338	0.162338
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00162338	0.162338
CEREBROCOSTOMANDIBULAR SYNDROME	0.00162338	0.162338
HISTIOCYTOID CARDIOMYOPATHY	0.00162338	0.162338
HEMIMELIA	0.00162338	0.162338
FEMORAL-FACIAL SYNDROME	0.00162338	0.162338
GENITOPALATOCARDIAC SYNDROME	0.00162338	0.162338
DISTAL MONOSOMY 7Q36	0.00162338	0.162338
PENTALOGY OF CANTRELL	0.00162338	0.162338
VAN DER WOUDE SYNDROME	0.00162338	0.162338
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00162338	0.162338
ACRORENAL SYNDROME	0.00162338	0.162338
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00162338	0.162338
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.00162338	0.162338
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.00162338	0.162338
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00162338	0.162338
MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	0.00162338	0.162338
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.00162338	0.162338
VACTERL/VATER ASSOCIATION	0.00162338	0.162338
HOLZGREVE SYNDROME	0.00162338	0.162338
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.00162338	0.162338
DYSTONIA, JUVENILE-ONSET	0.00162338	0.162338
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.00162338	0.162338
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00162338	0.162338
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.00162338	0.162338
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00162338	0.162338
OROFACIODIGITAL SYNDROME XI; OFD11	0.00162338	0.162338
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00162338	0.162338
HYDROLETHALUS SYNDROME 1	0.00162338	0.162338
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.00162338	0.162338
MCKUSICK-KAUFMAN SYNDROME	0.00162338	0.162338
%119530 OROFACIAL CLEFT 1; OFC1;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 1;;OROFACIAL CLEFT, NONSYNDROMIC; OFC;;CLEFT LIP/PALATE, NONSYNDROMIC	0.00162338	0.162338
PALATOPHARYNGEAL INCOMPETENCE	0.00162338	0.162338
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00162338	0.162338
DYSRAPHISM-CLEFT LIP/PALATE-LIMB REDUCTION DEFECTS SYNDROME	0.00162338	0.162338
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.00162338	0.162338
FIBROCHONDROGENESIS 1; FBCG1	0.00162338	0.162338
OROFACIODIGITAL SYNDROME X	0.00162338	0.162338
HOLZGREVE SYNDROME	0.00162338	0.162338
ATELOSTEOGENESIS, TYPE I; AO1	0.00162338	0.162338
POPLITEAL PTERYGIUM SYNDROME	0.00162338	0.162338
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.00156495	0.156495
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.00156495	0.156495
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00156495	0.156495
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00156495	0.156495
X-LINKED CENTRONUCLEAR MYOPATHY	0.00156495	0.156495
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00156495	0.156495
SPINOCEREBELLAR ATAXIA TYPE 28	0.00156495	0.156495
WIDOW'S PEAK SYNDROME	0.00156495	0.156495
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00156495	0.156495
GOOD SYNDROME	0.00156495	0.156495
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00156495	0.156495
OROFACIODIGITAL SYNDROME XVI; OFD16	0.00156495	0.156495
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00156495	0.156495
CONGENITAL MYASTHENIC SYNDROME	0.00156495	0.156495
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.00156495	0.156495
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00156495	0.156495
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00156495	0.156495
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.00156495	0.156495
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.00156495	0.156495
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00156495	0.156495
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00156495	0.156495
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00156495	0.156495
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00156495	0.156495
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00156495	0.156495
CENTRONUCLEAR MYOPATHY	0.00156495	0.156495
WAARDENBURG SYNDROME TYPE 2	0.00156495	0.156495
TYPICAL NEMALINE MYOPATHY	0.00156495	0.156495
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00156495	0.156495
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00156495	0.156495
HOLOPROSENCEPHALY 4	0.00156495	0.156495
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.00156495	0.156495
JOUBERT SYNDROME 7	0.00156495	0.156495
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00156495	0.156495
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00156495	0.156495
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00156495	0.156495
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00156495	0.156495
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00156495	0.156495
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00156495	0.156495
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00156495	0.156495
PRADER-WILLI-LIKE SYNDROME	0.00156495	0.156495
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00156495	0.156495
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00156495	0.156495
WAGR SYNDROME	0.00156495	0.156495
ARIMA SYNDROME	0.00156495	0.156495
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00156495	0.156495
PHACE SYNDROME	0.00156495	0.156495
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00156495	0.156495
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.00156495	0.156495
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.00156495	0.156495
THYMIC TUMOR	0.00156495	0.156495
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00156495	0.156495
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00156495	0.156495
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00156495	0.156495
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00156495	0.156495
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.00156495	0.156495
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00156495	0.156495
MEIER-GORLIN SYNDROME 8; MGORS8	0.00156495	0.156495
JOUBERT SYNDROME	0.00156495	0.156495
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00156495	0.156495
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.00156495	0.156495
BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	0.00156495	0.156495
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.00156495	0.156495
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.00156495	0.156495
HYPOTONIA-CYSTINURIA SYNDROME	0.00156495	0.156495
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.00156495	0.156495
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.00156495	0.156495
POSTERIOR FUSION OF LUMBOSACRAL VERTEBRAE-BLEPHAROPTOSIS SYNDROME	0.00156495	0.156495
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00156495	0.156495
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.00156495	0.156495
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00156495	0.156495
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.00156495	0.156495
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00156495	0.156495
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00156495	0.156495
PROLACTINOMA	0.00156495	0.156495
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.00156495	0.156495
OPHTHALMOPLEGIA, FAMILIAL STATIC	0.00156495	0.156495
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00156495	0.156495
JOUBERT SYNDROME 35; JBTS35	0.00156495	0.156495
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.00156495	0.156495
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00156495	0.156495
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00156495	0.156495
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00156495	0.156495
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00156495	0.156495
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00156495	0.156495
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00156495	0.156495
FACIOCARDIOMELIC SYNDROME	0.00156495	0.156495
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.00156495	0.156495
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00156495	0.156495
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.00156495	0.156495
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.00156495	0.156495
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.00156495	0.156495
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.00156495	0.156495
HYPOTONIA-CYSTINURIA SYNDROME	0.00156495	0.156495
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.00156495	0.156495
SCLEROSTEOSIS	0.00156495	0.156495
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00156495	0.156495
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00156495	0.156495
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00156495	0.156495
WERNICKE-KORSAKOFF SYNDROME	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00156495	0.156495
MARDEN-WALKER SYNDROME	0.00156495	0.156495
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00156495	0.156495
%300245 PTOSIS, HEREDITARY CONGENITAL 2;;PTOS2;;PTOSIS, X-LINKED; PTOSX	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.00156495	0.156495
HUNTER-MACDONALD SYNDROME	0.00156495	0.156495
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.00156495	0.156495
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00156495	0.156495
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.00156495	0.156495
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00156495	0.156495
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.00156495	0.156495
WARBURG MICRO SYNDROME 1	0.00156495	0.156495
OCULOFACIOCARDIODENTAL SYNDROME	0.00156495	0.156495
OCULOPHARYNGEAL MUSCULAR DYSTROPHY	0.00156495	0.156495
INTESTINAL BOTULISM	0.00156495	0.156495
ISOLATED COMPLEX I DEFICIENCY	0.00156495	0.156495
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00156495	0.156495
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.00156495	0.156495
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5; CFEOM5	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.00156495	0.156495
ADULT INTESTINAL BOTULISM	0.00156495	0.156495
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.00156495	0.156495
INFANT BOTULISM	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.00156495	0.156495
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00156495	0.156495
WOUND BOTULISM	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00156495	0.156495
KEARNS-SAYRE SYNDROME; KSS	0.00156495	0.156495
PITUITARY APOPLEXY	0.00156495	0.156495
MACHADO-JOSEPH DISEASE; MJD	0.00156495	0.156495
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00156495	0.156495
CODAS SYNDROME	0.00156495	0.156495
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00156495	0.156495
PACHYDERMOPERIOSTOSIS	0.00156495	0.156495
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.00156495	0.156495
INHALATIONAL BOTULISM	0.00156495	0.156495
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00156495	0.156495
IATROGENIC BOTULISM	0.00156495	0.156495
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.00156495	0.156495
CODAS SYNDROME	0.00156495	0.156495
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00156495	0.156495
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00156495	0.156495
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.00156495	0.156495
PAROXYSMAL HEMICRANIA	0.00156495	0.156495
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.00156495	0.156495
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.00156495	0.156495
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00156495	0.156495
RHYNS SYNDROME; RHYNS	0.00156495	0.156495
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00156495	0.156495
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00156495	0.156495
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00156495	0.156495
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	0.00156495	0.156495
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00156495	0.156495
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00156495	0.156495
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.00156495	0.156495
PURPURA SIMPLEX	0.00156495	0.156495
PROGRESSIVE HEMIFACIAL ATROPHY	0.00156495	0.156495
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00156495	0.156495
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.00156495	0.156495
TSH-SECRETING PITUITARY ADENOMA	0.00156495	0.156495
FETAL TRIMETHADIONE SYNDROME	0.00156495	0.156495
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00156495	0.156495
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.00156495	0.156495
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.00156495	0.156495
ERDHEIM-CHESTER DISEASE	0.00156495	0.156495
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00156495	0.156495
FOODBORNE BOTULISM	0.00156495	0.156495
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00156495	0.156495
ISOLATED CONGENITAL ALACRIMA	0.00156495	0.156495
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.00156495	0.156495
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00156495	0.156495
JOUBERT SYNDROME 21	0.00156495	0.156495
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.00156495	0.156495
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00156495	0.156495
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.00156495	0.156495
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.00156495	0.156495
SALIH MYOPATHY; SALMY	0.00156495	0.156495
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00156495	0.156495
NON-FUNCTIONING PITUITARY ADENOMA	0.00156495	0.156495
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.00156495	0.156495
THYMIC EPITHELIAL NEOPLASM	0.00156495	0.156495
TUKEL SYNDROME	0.00156495	0.156495
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.00156495	0.156495
POLYVALVULAR HEART DISEASE SYNDROME	0.00156495	0.156495
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00156495	0.156495
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.00156495	0.156495
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.00156495	0.156495
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00156495	0.156495
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00156495	0.156495
MYASTHENIA GRAVIS; MG	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00156495	0.156495
INFANTILE SIALIC ACID STORAGE DISEASE	0.00156495	0.156495
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.00156495	0.156495
REFSUM DISEASE	0.00156495	0.156495
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00156495	0.156495
LEIGH SYNDROME; LS	0.00156495	0.156495
MALIGNANT ATROPHIC PAPULOSIS	0.00156495	0.156495
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00156495	0.156495
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00156495	0.156495
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00156495	0.156495
CLUSTER HEADACHE, FAMILIAL	0.00156495	0.156495
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.00156495	0.156495
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00156495	0.156495
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00156495	0.156495
KAWASAKI DISEASE	0.00156495	0.156495
FRONTOOCULAR SYNDROME	0.00156495	0.156495
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00156495	0.156495
FETAL METHYLMERCURY SYNDROME	0.00151745	0.15174500000000002
OSTEOGENESIS IMPERFECTA	0.00151745	0.15174500000000002
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.00151745	0.15174500000000002
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.00151745	0.15174500000000002
TRANSIENT NEONATAL DIABETES MELLITUS	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.00151745	0.15174500000000002
TUNE DEAFNESS	0.00151745	0.15174500000000002
MENIERE DISEASE	0.00151745	0.15174500000000002
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00151745	0.15174500000000002
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00151745	0.15174500000000002
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.00151745	0.15174500000000002
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00151745	0.15174500000000002
184705 STEINFELD SYNDROME	0.00151745	0.15174500000000002
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00151745	0.15174500000000002
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.00151745	0.15174500000000002
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00151745	0.15174500000000002
GRACILE SYNDROME	0.00151745	0.15174500000000002
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00151745	0.15174500000000002
ACQUIRED PARTIAL LIPODYSTROPHY	0.00151745	0.15174500000000002
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00151745	0.15174500000000002
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.00151745	0.15174500000000002
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00151745	0.15174500000000002
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.00151745	0.15174500000000002
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00151745	0.15174500000000002
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00151745	0.15174500000000002
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00151745	0.15174500000000002
PAGET DISEASE OF BONE 3; PDB3	0.00151745	0.15174500000000002
PERMANENT NEONATAL DIABETES MELLITUS	0.00151745	0.15174500000000002
THANATOPHORIC DYSPLASIA TYPE 1	0.00151745	0.15174500000000002
NARP SYNDROME	0.00151745	0.15174500000000002
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.00151745	0.15174500000000002
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00151745	0.15174500000000002
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.00151745	0.15174500000000002
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00151745	0.15174500000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.00151745	0.15174500000000002
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.00151745	0.15174500000000002
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00151745	0.15174500000000002
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.00151745	0.15174500000000002
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00151745	0.15174500000000002
LASSA FEVER	0.00151745	0.15174500000000002
TURCOT SYNDROME WITH POLYPOSIS	0.00151745	0.15174500000000002
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00151745	0.15174500000000002
ANUS, IMPERFORATE	0.00151745	0.15174500000000002
BROOKE-SPIEGLER SYNDROME	0.00151745	0.15174500000000002
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.00151745	0.15174500000000002
ISOLATED ANORECTAL MALFORMATION	0.00151745	0.15174500000000002
WYBURN-MASON SYNDROME	0.00151745	0.15174500000000002
CRANIOPHARYNGIOMA	0.00151745	0.15174500000000002
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.00151745	0.15174500000000002
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00151745	0.15174500000000002
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00151745	0.15174500000000002
TOWNES-BROCKS SYNDROME	0.00151745	0.15174500000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00151745	0.15174500000000002
LEBER CONGENITAL AMAUROSIS	0.00151745	0.15174500000000002
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.00151745	0.15174500000000002
RETINAL VENOUS BEADING	0.00151745	0.15174500000000002
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.00151745	0.15174500000000002
OSTEOGENESIS IMPERFECTA, TYPE I	0.00151745	0.15174500000000002
IVIC SYNDROME	0.00151745	0.15174500000000002
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.00151745	0.15174500000000002
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00151745	0.15174500000000002
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00151745	0.15174500000000002
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00151745	0.15174500000000002
BRITTLE CORNEA SYNDROME 2; BCS2	0.00151745	0.15174500000000002
PULMONIC STENOSIS AND DEAFNESS	0.00151745	0.15174500000000002
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.00151745	0.15174500000000002
SANDHOFF DISEASE	0.00151745	0.15174500000000002
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00151745	0.15174500000000002
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00151745	0.15174500000000002
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.00151745	0.15174500000000002
COWDEN SYNDROME 6; CWS6	0.00151745	0.15174500000000002
CORNEODERMATOOSSEOUS SYNDROME	0.00151745	0.15174500000000002
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00151745	0.15174500000000002
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.00151745	0.15174500000000002
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.00151745	0.15174500000000002
SEVERE CANAVAN DISEASE	0.00151745	0.15174500000000002
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.00151745	0.15174500000000002
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00151745	0.15174500000000002
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00151745	0.15174500000000002
XYLOSIDASE DEFICIENCY	0.00151745	0.15174500000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00151745	0.15174500000000002
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.00151745	0.15174500000000002
LOCKED-IN SYNDROME	0.00151745	0.15174500000000002
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.00151745	0.15174500000000002
46,XX GONADAL DYSGENESIS	0.00151745	0.15174500000000002
ARACHNOIDITIS	0.00151745	0.15174500000000002
RFT1-CDG	0.00151745	0.15174500000000002
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00151745	0.15174500000000002
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.00151745	0.15174500000000002
PITUITARY CARCINOMA	0.00151745	0.15174500000000002
DEAFNESS, X-LINKED 5; DFNX5	0.00151745	0.15174500000000002
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.00151745	0.15174500000000002
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.00151745	0.15174500000000002
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.00151745	0.15174500000000002
BRANCHIOOTIC SYNDROME 2	0.00151745	0.15174500000000002
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00151745	0.15174500000000002
WARSAW BREAKAGE SYNDROME; WABS	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00151745	0.15174500000000002
VIRAL HEMORRHAGIC FEVER	0.00151745	0.15174500000000002
CONGENITAL VELOPHARYNGEAL INCOMPETENCE	0.00151745	0.15174500000000002
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00151745	0.15174500000000002
IVIC SYNDROME	0.00151745	0.15174500000000002
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00151745	0.15174500000000002
RETICULAR DYSGENESIS	0.00151745	0.15174500000000002
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00151745	0.15174500000000002
WALDENSTRÖM MACROGLOBULINEMIA	0.00151745	0.15174500000000002
THALIDOMIDE EMBRYOPATHY	0.00151745	0.15174500000000002
CARNEY-STRATAKIS SYNDROME	0.00151745	0.15174500000000002
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00151745	0.15174500000000002
RAMON SYNDROME	0.00151745	0.15174500000000002
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.00151745	0.15174500000000002
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.00151745	0.15174500000000002
COWDEN SYNDROME 5; CWS5	0.00151745	0.15174500000000002
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00151745	0.15174500000000002
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00151745	0.15174500000000002
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00151745	0.15174500000000002
COXOAURICULAR SYNDROME	0.00151745	0.15174500000000002
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00151745	0.15174500000000002
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00151745	0.15174500000000002
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00151745	0.15174500000000002
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.00151745	0.15174500000000002
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00151745	0.15174500000000002
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.00151745	0.15174500000000002
N SYNDROME	0.00151745	0.15174500000000002
LISSENCEPHALY 5; LIS5	0.00151745	0.15174500000000002
COXOAURICULAR SYNDROME	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.00151745	0.15174500000000002
DEMENTIA, FAMILIAL DANISH	0.00151745	0.15174500000000002
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.00151745	0.15174500000000002
17Q12 MICRODELETION SYNDROME	0.00151745	0.15174500000000002
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00151745	0.15174500000000002
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.00151745	0.15174500000000002
SPASTIC PARAPARESIS AND DEAFNESS	0.00151745	0.15174500000000002
NAIL-PATELLA SYNDROME	0.00151745	0.15174500000000002
WILDERVANCK SYNDROME	0.00151745	0.15174500000000002
COFFIN-SIRIS SYNDROME 4; CSS4	0.00151745	0.15174500000000002
EAR-PATELLA-SHORT STATURE SYNDROME	0.00151745	0.15174500000000002
RENAL COLOBOMA SYNDROME	0.00151745	0.15174500000000002
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.00151745	0.15174500000000002
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00151745	0.15174500000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00151745	0.15174500000000002
RICHARDS-RUNDLE SYNDROME	0.00151745	0.15174500000000002
USHER SYNDROME, TYPE ID	0.00151745	0.15174500000000002
COFFIN-SIRIS SYNDROME 3; CSS3	0.00151745	0.15174500000000002
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00151745	0.15174500000000002
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00151745	0.15174500000000002
OTOSCLEROSIS 8; OTSC8	0.00151745	0.15174500000000002
6P22 MICRODELETION SYNDROME	0.00151745	0.15174500000000002
CHIARI MALFORMATION TYPE I	0.00151745	0.15174500000000002
AUROCEPHALOSYNDACTYLY	0.00151745	0.15174500000000002
FRIEDREICH ATAXIA	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.00151745	0.15174500000000002
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00151745	0.15174500000000002
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00151745	0.15174500000000002
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00151745	0.15174500000000002
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00151745	0.15174500000000002
CONE-ROD DYSTROPHY 1; CORD1	0.00151745	0.15174500000000002
ABCD SYNDROME	0.00151745	0.15174500000000002
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00151745	0.15174500000000002
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.00151745	0.15174500000000002
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.00151745	0.15174500000000002
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.00151745	0.15174500000000002
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.00151745	0.15174500000000002
HURLER SYNDROME	0.00151745	0.15174500000000002
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.00151745	0.15174500000000002
CONGENITAL HYPOTHYROIDISM	0.00151745	0.15174500000000002
NEUROFIBROMATOSIS, TYPE II	0.00151745	0.15174500000000002
X-LINKED HYPOPHOSPHATEMIA	0.00151745	0.15174500000000002
ISOLATED PLAGIOCEPHALY	0.00151745	0.15174500000000002
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.00151745	0.15174500000000002
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00151745	0.15174500000000002
KEARNS-SAYRE SYNDROME	0.00151745	0.15174500000000002
SENSORINEURAL DEAFNESS WITH DILATED CARDIOMYOPATHY	0.00151745	0.15174500000000002
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.00151745	0.15174500000000002
KEUTEL SYNDROME; KTLS	0.00151745	0.15174500000000002
PEROXISOME BIOGENESIS DISORDER 11B	0.00151745	0.15174500000000002
TIETZ SYNDROME	0.00151745	0.15174500000000002
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00151745	0.15174500000000002
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.00151745	0.15174500000000002
GYRATE ATROPHY OF CHOROID AND RETINA	0.00151745	0.15174500000000002
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.00151745	0.15174500000000002
FANCONI ANEMIA	0.00151745	0.15174500000000002
SPINOCEREBELLAR ATAXIA TYPE 13	0.00151745	0.15174500000000002
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.00151745	0.15174500000000002
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.00151745	0.15174500000000002
GLYCOGEN STORAGE DISEASE II	0.00151745	0.15174500000000002
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.00151745	0.15174500000000002
BRITTLE CORNEA SYNDROME	0.00151745	0.15174500000000002
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.00151745	0.15174500000000002
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00151745	0.15174500000000002
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00151745	0.15174500000000002
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00151745	0.15174500000000002
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00151745	0.15174500000000002
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.00151745	0.15174500000000002
HYDROXYKYNURENINURIA	0.00151745	0.15174500000000002
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00151745	0.15174500000000002
FETAL IODINE DEFICIENCY DISORDER	0.00151745	0.15174500000000002
SLC39A8-CDG	0.00151745	0.15174500000000002
SPINOCEREBELLAR ATAXIA TYPE 31	0.00151745	0.15174500000000002
SPINOCEREBELLAR ATAXIA TYPE 18	0.00151745	0.15174500000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00151745	0.15174500000000002
USHER SYNDROME, TYPE IID; USH2D	0.00151745	0.15174500000000002
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00151745	0.15174500000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.00151745	0.15174500000000002
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00151745	0.15174500000000002
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.00151745	0.15174500000000002
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.00151745	0.15174500000000002
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.00151745	0.15174500000000002
NATHALIE SYNDROME	0.00151745	0.15174500000000002
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.00151745	0.15174500000000002
SPINOCEREBELLAR ATAXIA 13	0.00151745	0.15174500000000002
OTOSCLEROSIS 3; OTSC3	0.00151745	0.15174500000000002
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.00151745	0.15174500000000002
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.00151745	0.15174500000000002
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.00151745	0.15174500000000002
CRIGLER-NAJJAR SYNDROME	0.00151745	0.15174500000000002
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00151745	0.15174500000000002
LYMPHEDEMA, HEREDITARY, III	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00151745	0.15174500000000002
GALACTOSIALIDOSIS	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL DOMINANT 24	0.00151745	0.15174500000000002
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.00151745	0.15174500000000002
BETA-MANNOSIDOSIS	0.00151745	0.15174500000000002
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00151745	0.15174500000000002
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.00151745	0.15174500000000002
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.00151745	0.15174500000000002
CAMURATI-ENGELMANN DISEASE	0.00151745	0.15174500000000002
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00151745	0.15174500000000002
PAGET DISEASE OF BONE 4; PDB4	0.00151745	0.15174500000000002
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.00151745	0.15174500000000002
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00151745	0.15174500000000002
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.00151745	0.15174500000000002
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00151745	0.15174500000000002
EAR EXOSTOSES	0.00151745	0.15174500000000002
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.00151745	0.15174500000000002
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00151745	0.15174500000000002
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00151745	0.15174500000000002
MORQUIO SYNDROME A	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.00151745	0.15174500000000002
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00151745	0.15174500000000002
HYPERTELORISM	0.00098912	0.098912
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.00098912	0.098912
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00098912	0.098912
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00098912	0.098912
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00098912	0.098912
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00098912	0.098912
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00098912	0.098912
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00098912	0.098912
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00098912	0.098912
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.00098912	0.098912
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.00098912	0.098912
KBG SYNDROME	0.00098912	0.098912
CROUZON SYNDROME	0.00098912	0.098912
POSTERIOR URETHRAL VALVE	0.00098912	0.098912
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00098912	0.098912
TRICHOHEPATOENTERIC SYNDROME 2	0.00098912	0.098912
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00098912	0.098912
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.00098912	0.098912
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.00098912	0.098912
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00098912	0.098912
AUTOSOMAL DOMINANT OMODYSPLASIA	0.00098912	0.098912
AUTOSOMAL DOMINANT CUTIS LAXA	0.00098912	0.098912
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.00098912	0.098912
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00098912	0.098912
GASTROCUTANEOUS SYNDROME	0.00098912	0.098912
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00098912	0.098912
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00098912	0.098912
X SMALL RINGS	0.00098912	0.098912
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.00098912	0.098912
ALAGILLE SYNDROME 1; ALGS1	0.00098912	0.098912
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00098912	0.098912
TEMTAMY SYNDROME	0.00098912	0.098912
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.00098912	0.098912
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.00098912	0.098912
14Q11.2 MICRODELETION SYNDROME	0.00098912	0.098912
OSTEOGLOSPHONIC DYSPLASIA	0.00098912	0.098912
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00098912	0.098912
CHST3-RELATED SKELETAL DYSPLASIA	0.00098912	0.098912
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.00098912	0.098912
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00098912	0.098912
XP21 MICRODELETION SYNDROME	0.00098912	0.098912
DIAMOND-BLACKFAN ANEMIA 5	0.00098912	0.098912
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00098912	0.098912
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.00098912	0.098912
CURRY-JONES SYNDROME	0.00098912	0.098912
NEU-LAXOVA SYNDROME	0.00098912	0.098912
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00098912	0.098912
CRANIOSYNOSTOSIS 4; CRS4	0.00098912	0.098912
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00098912	0.098912
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.00098912	0.098912
8P11.2 DELETION SYNDROME	0.00098912	0.098912
1Q21.1 MICRODUPLICATION SYNDROME	0.00098912	0.098912
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00098912	0.098912
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.00098912	0.098912
WHITE FORELOCK WITH MALFORMATIONS	0.00098912	0.098912
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00098912	0.098912
BIFID NOSE	0.00098912	0.098912
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.00098912	0.098912
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00098912	0.098912
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.00098912	0.098912
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.00098912	0.098912
OROFACIODIGITAL SYNDROME TYPE 5	0.00098912	0.098912
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.00098912	0.098912
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00098912	0.098912
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00098912	0.098912
MENTAL RETARDATION, X-LINKED 106; MRX106	0.00098912	0.098912
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00098912	0.098912
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.00098912	0.098912
KEIPERT SYNDROME; KPTS	0.00098912	0.098912
OCULOTRICHOANAL SYNDROME	0.00098912	0.098912
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00098912	0.098912
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.00098912	0.098912
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00098912	0.098912
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00098912	0.098912
GLYCEROL KINASE DEFICIENCY; GKD	0.00098912	0.098912
OROFACIODIGITAL SYNDROME TYPE 4	0.00098912	0.098912
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.00098912	0.098912
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00098912	0.098912
VICI SYNDROME	0.00098912	0.098912
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.00098912	0.098912
DISTAL MONOSOMY 17Q	0.00098912	0.098912
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00098912	0.098912
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00098912	0.098912
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.00098912	0.098912
INTERMEDIATE NEMALINE MYOPATHY	0.00098912	0.098912
%608572 BURN-MCKEOWN SYNDROME	0.00098912	0.098912
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.00098912	0.098912
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.00098912	0.098912
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.00098912	0.098912
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00098912	0.098912
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00098912	0.098912
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.00098912	0.098912
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00098912	0.098912
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.00098912	0.098912
FRONTAL ENCEPHALOCELE	0.00098912	0.098912
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.00098912	0.098912
PHENOBARBITAL EMBRYOPATHY	0.00098912	0.098912
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00098912	0.098912
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00098912	0.098912
PACHYGYRIA, FRONTOTEMPORAL	0.00098912	0.098912
HOLOPROSENCEPHALY 5; HPE5	0.00098912	0.098912
DYSOSTOSIS, STANESCU TYPE	0.00098912	0.098912
THAKKER-DONNAI SYNDROME	0.00098912	0.098912
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00098912	0.098912
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00098912	0.098912
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00098912	0.098912
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.00098912	0.098912
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.00098912	0.098912
LAURIN-SANDROW SYNDROME	0.00098912	0.098912
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.00098912	0.098912
TEMPLE-BARAITSER SYNDROME; TMBTS	0.00098912	0.098912
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00098912	0.098912
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00098912	0.098912
ICF SYNDROME	0.00098912	0.098912
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00098912	0.098912
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00098912	0.098912
PSEUDOAMINOPTERIN SYNDROME	0.00098912	0.098912
GASTROCUTANEOUS SYNDROME	0.00098912	0.098912
WORMIAN BONE-MULTIPLE FRACTURES-DENTINOGENESIS IMPERFECTA-SKELETAL DYSPLASIA	0.00098912	0.098912
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00098912	0.098912
DUANE-RADIAL RAY SYNDROME; DRRS	0.00098912	0.098912
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.00098912	0.098912
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00098912	0.098912
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00098912	0.098912
GAUCHER DISEASE, PERINATAL LETHAL	0.00098912	0.098912
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00098912	0.098912
JOUBERT SYNDROME 2	0.00098912	0.098912
QAZI-MARKOUIZOS SYNDROME	0.00098912	0.098912
RENAL TUBULAR DYSGENESIS	0.00098912	0.098912
DELAYED MEMBRANOUS CRANIAL OSSIFICATION	0.00098912	0.098912
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.00098912	0.098912
MARSHALL-SMITH SYNDROME	0.00098912	0.098912
JOUBERT SYNDROME 32; JBTS32	0.00098912	0.098912
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.00098912	0.098912
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00098912	0.098912
FAMILIAL INTESTINAL MALROTATION	0.00098912	0.098912
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.00098912	0.098912
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.00098912	0.098912
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00098912	0.098912
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.00098912	0.098912
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.00098912	0.098912
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.00098912	0.098912
RAMOS-ARROYO SYNDROME	0.00098912	0.098912
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00098912	0.098912
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00098912	0.098912
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00098912	0.098912
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00098912	0.098912
ANOPHTHALMIA PLUS SYNDROME	0.00098912	0.098912
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00098912	0.098912
CONO-SPONDYLAR DYSPLASIA	0.00098912	0.098912
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.00098912	0.098912
ATELOSTEOGENESIS TYPE II	0.00098912	0.098912
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00098912	0.098912
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.00098912	0.098912
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.00098912	0.098912
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00098912	0.098912
SPONDYLO-OCULAR SYNDROME	0.00098912	0.098912
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.00098912	0.098912
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00098912	0.098912
NEUROFIBROMATOSIS, TYPE I	0.00098912	0.098912
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.00098912	0.098912
SCHINZEL-GIEDION SYNDROME	0.00098912	0.098912
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.00098912	0.098912
OROFACIODIGITAL SYNDROME V; OFD5	0.00098912	0.098912
ROBINOW-SORAUF SYNDROME	0.00098912	0.098912
ADAMS-OLIVER SYNDROME 2; AOS2	0.00098912	0.098912
SCHIZOPHRENIA 1; SCZD1	0.00098912	0.098912
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.00098912	0.098912
CEREBROOCULONASAL SYNDROME	0.00098912	0.098912
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00098912	0.098912
WIDOW'S PEAK	0.00098912	0.098912
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00098912	0.098912
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00098912	0.098912
LOEYS-DIETZ SYNDROME	0.00098912	0.098912
RHOMBENCEPHALOSYNAPSIS	0.00098912	0.098912
LAMBOTTE SYNDROME	0.00098912	0.098912
ISOLATED ARRHINIA	0.00098912	0.098912
MANITOBA OCULOTRICHOANAL SYNDROME	0.00098912	0.098912
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.00098912	0.098912
ARTERIAL TORTUOSITY SYNDROME	0.00098912	0.098912
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00098912	0.098912
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00098912	0.098912
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00098912	0.098912
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.00098912	0.098912
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00098912	0.098912
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00098912	0.098912
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00098912	0.098912
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.00098912	0.098912
SUMMITT SYNDROME	0.00098912	0.098912
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00098912	0.098912
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00098912	0.098912
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.00098912	0.098912
RESTRICTIVE DERMOPATHY, LETHAL	0.00098912	0.098912
WHITE FORELOCK WITH MALFORMATIONS	0.00098912	0.098912
FGFR2-RELATED BENT BONE DYSPLASIA	0.00098912	0.098912
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.00098912	0.098912
MENTAL RETARDATION, X-LINKED 21	0.00098912	0.098912
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00098912	0.098912
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.00098912	0.098912
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00098912	0.098912
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.00098912	0.098912
DOUBLE OUTLET RIGHT VENTRICLE	0.00098912	0.098912
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.00098912	0.098912
OROFACIAL CLEFT 15	0.00098912	0.098912
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.00098912	0.098912
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00098912	0.098912
CHROMOSOME 4Q21 DELETION SYNDROME	0.00098912	0.098912
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00098912	0.098912
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00098912	0.098912
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00098912	0.098912
NASODIGITOACOUSTIC SYNDROME	0.00098912	0.098912
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.00098912	0.098912
DISTAL MONOSOMY 1Q	0.00098912	0.098912
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00098912	0.098912
ACROCALLOSAL SYNDROME	0.00098912	0.098912
ATKIN-FLAITZ SYNDROME	0.00098912	0.098912
ROIFMAN SYNDROME	0.00098912	0.098912
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.00098912	0.098912
OPSISMODYSPLASIA; OPSMD	0.00098912	0.098912
OROFACIODIGITAL SYNDROME III	0.00098912	0.098912
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00098912	0.098912
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00098912	0.098912
NF1-MICRODELETION SYNDROME	0.00098912	0.098912
